Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)
x 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
For the quarter ended June 30, 2010
OR
 
¨ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
For the transition period from                      to                     
Commission file number 1-15477

MAXWELL TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

Delaware	 	95-2390133	
(State or other jurisdiction of
incorporation or organization)	 	(I.R.S. Employer
Identification No.)	
		
5271 Viewridge Court, Suite 100, San Diego, California	 	92123	
(Address of principal executive offices)	 	(Zip Code)	
(858) 503-3200
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES  x  NO  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES  ¨  NO  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer   ¨	 	Accelerated filer   x	 	Non-accelerated filer   ¨	 	Smaller reporting company   ¨	
	 		 	(Do not check if a smaller reporting company)	
Indicate by check mark whether the registrant is a shell Company (as defined in Rule 12b-2 of the Act).    YES   ¨     NO   x
The number of shares of the registrant’s Common Stock outstanding as of July 31, 2010 is 26,456,221 shares.

 

Table of Contents
 TABLE OF CONTENTS
MAXWELL TECHNOLOGIES, INC.
INDEX TO QUARTERLY REPORT ON FORM 10-Q
For the quarter ended June 30, 2010

 	 	 	  	Page	
PART I – Financial Information	
			
Item 1.	 	Financial Statements (Unaudited):	  	3	
			
	 	Condensed Consolidated Balance Sheets as of June 30, 2010 and December 31, 2009	  	4	
			
	 	Condensed Consolidated Statements of Operations – Three and six months ended June 30, 2010 and 2009	  	5	
			
	 	Condensed Consolidated Statements of Cash Flows – Six months ended June 30, 2010 and 2009	  	6	
			
	 	Notes to Condensed Consolidated Financial Statements	  	7	
			
Item 2.	 	Management’s Discussion and Analysis of Financial Condition and Results of Operations	  	18	
			
Item 3.	 	Quantitative and Qualitative Disclosures About Market Risk	  	27	
			
Item 4.	 	Controls and Procedures	  	27	
		
PART II – Other Information	  	28	
			
Item 1.	 	Legal Proceedings	  	28	
			
Item 1A.	 	Risk Factors	  	28	
			
Item 6.	 	Exhibits	  	28	
		
Signatures	  	29	
 
2

Table of Contents
 PART I – Financial Information
 
 Item 1.	Financial Statements	
The following condensed consolidated balance sheet as of December 31, 2009, which has been derived from audited financial statements, and the unaudited interim condensed consolidated financial statements, consisting of the condensed consolidated balance sheet as of June 30, 2010, the condensed consolidated statements of operations for the three and six months ended June 30, 2010 and 2009, and the condensed consolidated statements of cash flows for the six months ended June 30, 2010 and 2009, have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.
The following condensed balance sheet as of December 31, 2009, which has been derived from audited financial statements, does not include all of the information and footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009. It is suggested that these condensed financial statements be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009.
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. In the opinion of management, these unaudited statements contain all adjustments (consisting of normal recurring adjustments, except as otherwise indicated) necessary for a fair presentation for the periods presented as required by Regulation S-X, Rule 10-01.
Actual results could differ materially from those estimates. In addition, operating results for the three and six months ended June 30, 2010 are not necessarily indicative of the results that may be expected for any subsequent period or for the year ending December 31, 2010.
 
3

Table of Contents
 MAXWELL TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)

 	  	June 30,
2010
(Unaudited)	 	 	December 31,
2009	 	
ASSETS	  				 				
Current assets:	  				 				
Cash and cash equivalents	  	$	28,201	  	 	$	29,582	  	
Trade and other accounts receivable, net of allowance for doubtful accounts of $354 and $386 at June 30, 2010 and December 31, 2009, respectively	  	 	24,675	  	 	 	20,485	  	
Inventories, net	  	 	17,808	  	 	 	17,788	  	
Prepaid expenses and other current assets	  	 	2,034	  	 	 	1,776	  	
	  	 	 	 	 	 	 	 	
Total current assets	  	 	72,718	  	 	 	69,631	  	
Property and equipment, net	  	 	17,406	  	 	 	17,080	  	
Intangible assets, net	  	 	1,809	  	 	 	2,922	  	
Goodwill	  	 	22,016	  	 	 	22,799	  	
Prepaid pension asset	  	 	7,757	  	 	 	7,653	  	
Restricted cash	  	 	8,000	  	 	 	8,000	  	
Other non-current assets	  	 	1,128	  	 	 	734	  	
	  	 	 	 	 	 	 	 	
Total assets	  	$	130,834	  	 	$	128,819	  	

LIABILITIES AND STOCKHOLDERS’ EQUITY	  				 				
Current liabilities:	  				 				
Accounts payable and accrued liabilities	  	$	31,430	  	 	$	23,672	  	
Accrued warranty	  	 	501	  	 	 	588	  	
Accrued employee compensation	  	 	5,199	  	 	 	4,615	  	
Short-term borrowings and current portion of long-term debt	  	 	7,820	  	 	 	5,245	  	
Stock warrants	  	 	239	  	 	 	2,465	  	
Deferred tax liability	  	 	906	  	 	 	906	  	
	  	 	 	 	 	 	 	 	
Total current liabilities	  	 	46,095	  	 	 	37,491	  	
Deferred tax liability, long-term	  	 	1,097	  	 	 	1,097	  	
Convertible debenture and long-term debt, excluding current portion	  	 	6,280	  	 	 	11,452	  	
Other long-term liabilities	  	 	726	  	 	 	787	  	
	  	 	 	 	 	 	 	 	
Total liabilities	  	 	54,198	  	 	 	50,827	  	
	  	 	 	 	 	 	 	 	
Commitments and contingencies	  				 				
Stockholders’ equity:	  				 				
Common stock, $0.10 par value per share, 40,000 shares authorized; 26,403 and 26,321 shares issued and outstanding at June 30, 2010 and December 31, 2009, respectively	  	 	2,641	  	 	 	2,633	  	
Additional paid-in capital	  	 	226,321	  	 	 	224,575	  	
Accumulated deficit	  	 	(159,156	) 	 	 	(157,814	) 	
Accumulated other comprehensive income	  	 	6,830	  	 	 	8,598	  	
	  	 	 	 	 	 	 	 	
Total stockholders’ equity	  	 	76,636	  	 	 	77,992	  	
	  	 	 	 	 	 	 	 	
Total liabilities and stockholders’ equity	  	$	130,834	  	 	$	128,819	  	
	  	 	 	 	 	 	 	 	
See accompanying notes to condensed consolidated financial statements.
 
4

Table of Contents
 MAXWELL TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(Unaudited)

 	  	Three Months Ended
June 30,	 	 	Six Months Ended
June 30,	 	
 	  	2010	 	 	2009	 	 	2010	 	 	2009	 	
Sales	  	$	29,579	  	 	$	24,754	  	 	$	56,202	  	 	$	47,213	  	
Cost of sales	  	 	17,742	  	 	 	15,839	  	 	 	34,154	  	 	 	31,245	  	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Gross profit	  	 	11,837	  	 	 	8,915	  	 	 	22,048	  	 	 	15,968	  	
Operating expenses:	  				 				 				 				
Selling, general and administrative	  	 	11,164	  	 	 	5,628	  	 	 	18,339	  	 	 	10,674	  	
Research and development	  	 	3,954	  	 	 	4,098	  	 	 	8,536	  	 	 	7,792	  	
Amortization of intangibles	  	 	51	  	 	 	87	  	 	 	132	  	 	 	181	  	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total operating expenses	  	 	15,169	  	 	 	9,813	  	 	 	27,007	  	 	 	18,647	  	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Loss from operations	  	 	(3,332	) 	 	 	(898	) 	 	 	(4,959	) 	 	 	(2,679	) 	
Interest expense, net	  	 	(48	) 	 	 	(68	) 	 	 	(98	) 	 	 	(143	) 	
Amortization of debt discount and prepaid debt costs	  	 	(20	) 	 	 	(243	) 	 	 	(41	) 	 	 	(622	) 	
Gain (loss) on embedded derivatives and warrants	  	 	1,226	  	 	 	(3,807	) 	 	 	4,475	  	 	 	(4,414	) 	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Loss from continuing operations before income taxes	  	 	(2,174	) 	 	 	(5,016	) 	 	 	(623	) 	 	 	(7,858	) 	
Income tax provision	  	 	410	  	 	 	319	  	 	 	719	  	 	 	442	  	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net loss	  	$	(2,584	) 	 	$	(5,335	) 	 	$	(1,342	) 	 	$	(8,300	) 	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net loss per share:	  				 				 				 				
Basic and diluted	  	$	(0.10	) 	 	$	(0.22	) 	 	$	(0.05	) 	 	$	(0.36	) 	
Weighted average common shares outstanding:	  				 				 				 				
Basic and diluted	  	 	26,155	  	 	 	23,862	  	 	 	26,125	  	 	 	23,108	  	
See accompanying notes to condensed consolidated financial statements.
 
5

Table of Contents
 MAXWELL TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)

 	  	Six Months Ended
June 30,	 	
 	  	2010	 	 	2009	 	
OPERATING ACTIVITIES:	  				 				
Net loss	  	$	(1,342	) 	 	$	(8,300	) 	
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:	  				 				
Depreciation	  	 	2,738	  	 	 	2,591	  	
Amortization	  	 	277	  	 	 	319	  	
Amortization of debt discount and prepaid debt costs	  	 	41	  	 	 	622	  	
Loss (gain) on embedded derivatives and warrants	  	 	(4,475	) 	 	 	4,414	  	
Pension cost (benefit)	  	 	(100	) 	 	 	204	  	
Stock-based compensation	  	 	1,366	  	 	 	1,579	  	
Shares issued for interest payments	  	 	—  	  	 	 	92	  	
Provision for losses on accounts receivable	  	 	30	  	 	 	24	  	
Changes in operating assets and liabilities:	  				 				
Trade and other accounts receivable	  	 	(3,928	) 	 	 	(4,955	) 	
Inventories	  	 	(300	) 	 	 	(842	) 	
Prepaid expenses and other assets	  	 	63	  	 	 	(282	) 	
Accounts payable and accrued liabilities	  	 	7,936	  	 	 	2,700	  	
Accrued employee compensation	  	 	625	  	 	 	1,296	  	
Other long-term liabilities	  	 	(43	) 	 	 	(36	) 	
	  	 	 	 	 	 	 	 	
Net cash provided by (used in) operating activities	  	 	2,888	  	 	 	(574	) 	
	  	 	 	 	 	 	 	 	
INVESTING ACTIVITIES:	  				 				
Purchases of property and equipment	  	 	(3,308	) 	 	 	(2,159	) 	
	  	 	 	 	 	 	 	 	
Net cash used in investing activities	  	 	(3,308	) 	 	 	(2,159	) 	
	  	 	 	 	 	 	 	 	
FINANCING ACTIVITIES:	  				 				
Principal payments on long-term debt and short-term borrowings	  	 	(6,007	) 	 	 	(4,957	) 	
Proceeds from long-term and short-term borrowings	  	 	5,791	  	 	 	1,744	  	
Retirement of shares	  	 	(122	) 	 	 	(20	) 	
Net cash proceeds from issuance of common stock	  	 	510	  	 	 	24,957	  	
	  	 	 	 	 	 	 	 	
Net cash provided by financing activities	  	 	172	  	 	 	21,724	  	
	  	 	 	 	 	 	 	 	
Increase (decrease) in cash and cash equivalents from operations	  	 	(248	) 	 	 	18,991	  	
Effect of exchange rate changes on cash and cash equivalents	  	 	(1,133	) 	 	 	(51	) 	
	  	 	 	 	 	 	 	 	
Increase (decrease) in cash and cash equivalents	  	 	(1,381	) 	 	 	18,940	  	
Cash and cash equivalents, beginning of period	  	 	29,582	  	 	 	12,576	  	
	  	 	 	 	 	 	 	 	
Cash and cash equivalents, end of period	  	$	28,201	  	 	$	31,516	  	
	  	 	 	 	 	 	 	 	
See accompanying notes to condensed consolidated financial statements.
 
6

Table of Contents
 MAXWELL TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Unless the context otherwise requires, all references to “Maxwell” and the “Company” refer to Maxwell Technologies, Inc. and its subsidiaries; all references to “Maxwell SA” refer to our European Subsidiary, Maxwell Technologies, SA.
Note 1 – Description of Business and Summary of Significant Accounting Policies
Description of Business
Maxwell Technologies, Inc. is a Delaware corporation originally incorporated in 1965 under the name Maxwell Laboratories, Inc. In 1996, the Company changed its name to Maxwell Technologies, Inc.
Maxwell has two manufacturing locations (San Diego, California and Rossens, Switzerland). In addition, the Company has two contract manufacturers, located in Shenzhen, China and Tianjin, China. Maxwell operates as one operating segment called High Reliability, which is comprised of three product lines:
 
 	•	 	Ultracapacitors: The Company’s primary focus is on ultracapacitors, energy storage devices that possess a unique combination of high power density, long operational life and the ability to charge and discharge very rapidly. The Company’s BOOSTCAP ® ultracapacitor cells and multi-cell modules provide highly reliable energy storage and power delivery solutions for applications in multiple industries, including transportation, automotive, telecommunications, renewable energy and consumer and industrial electronics.	
 
 	•	 	High-Voltage Capacitors: The Company’s CONDIS ® high-voltage capacitors are extremely robust devices that are designed and manufactured to perform reliably for decades in all climates. These products include grading and coupling capacitors and capacitive voltage dividers that are used to ensure the safety and reliability of electric utility infrastructure and other applications involving transport, distribution and measurement of high-voltage electrical energy.	
 
 	•	 	Radiation-Mitigated Microelectronic Products: The Company’s radiation-mitigated microelectronic products include high-performance, high-density power modules, memory modules and single board computers that incorporate the Company’s proprietary RADPAK ® packaging and shielding technology and novel architectures that enable them to withstand environmental radiation effects and perform reliably in space.	
The Company’s products are designed and manufactured to perform reliably for the life of the products and systems into which they are integrated. The Company achieves high reliability through the application of proprietary technologies and rigorously controlled design, development, manufacturing and test processes.
Basis of Presentation
The accompanying condensed consolidated financial statements include the accounts of Maxwell Technologies, Inc. and its subsidiaries. All significant intercompany transactions and account balances have been eliminated in consolidation. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with the instructions to Form 10-Q and the standards of accounting measurement set forth in the Interim Reporting Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”). Consequently, the Company has not necessarily included in this Form 10-Q all information and footnotes required for audited financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements in this Form 10-Q contain all adjustments (consisting only of normal recurring adjustments, except as otherwise indicated) necessary to present fairly the financial position, results of operations, and cash flows of Maxwell Technologies, Inc. for all periods presented. The results reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for any subsequent period or for the entire year. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s latest Annual Report on Form 10-K. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted in the accompanying interim consolidated financial statements.
Liquidity
As of June 30, 2010, the Company had approximately $28.2 million in cash and cash equivalents with an additional $8.0 million in restricted cash for a total of $36.2 million. The cash restriction will be released when the convertible debenture is fully repaid or converted.
Based on the Company’s assessment of its current and long-term obligations, management believes it will have adequate resources to fund working capital requirements, obligations as they become due, capital equipment additions and product development expenditures for the next several years.
 
7

Table of Contents
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts and related disclosures. Estimates have been prepared on the basis of the most current information available. These estimates include, but are not limited to, assessing the collectability of accounts receivable, applied and unapplied production costs, production capacities, the usage and recoverability of inventories and long-lived assets, provisions for deferred income taxes, the incurrence of warranty obligations, stock compensation expense, impairment of goodwill and other intangible assets, estimations of the cost to complete certain projects, recoverability of patents, estimation of the probability that the performance criteria of restricted stock awards will be met and the fair value of warrants and embedded conversion options related to convertible debentures. The markets for the Company’s products are extremely competitive and are characterized by rapid technological change, new product development, product obsolescence and evolving industry standards. In addition, price competition is intense and significant price erosion may occur over the life of a product. As a result of such factors, actual results could differ materially from the estimates used by management.
Revenue Recognition
Sales revenue is derived from the sale of manufactured products directly to customers. For certain long-term contracts, revenue is recognized at the time costs are incurred. Product revenue is recognized, according to the guidelines of the Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) Numbers 101, Revenue Recognition in Financial Statements , and 104, Revenue Recognition , when all of the following criteria are met: (1) persuasive evidence of an arrangement exists (upon contract signing or receipt of an authorized purchase order from a customer); (2) title passes to the customer at either shipment from the Company’s facilities or receipt at the customer facility, depending on shipping terms; (3) customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collectability is reasonably assured. If a volume discount is offered, revenue is recognized at the lowest price to the customer. This method has been consistently applied from period to period and there is no right of return.
Revenue generated from fixed price contracts is recognized on a percentage of completion basis measured by the percentage of cost incurred to date to the estimated costs for each contract, as required by the Construction-Type and Production-Type Contracts Subtopic of the FASB ASC, and is limited by the funding of the prime contractor. Provisions for estimated losses on incomplete contracts are made in the period in which such losses are determined.
From time to time the Company has entered into multiple-element contractual arrangements with elements of software that are essential to the functionality of the delivered elements. Additionally, the Company has contracts where all the elements of the agreement need to be delivered and accepted by the customer prior to any revenue being recognized for the deliverables. The Company recognizes revenue on the delivered elements when vendor-specific objective evidence (“VSOE”) of the fair value of the undelivered elements exists in accordance with the Software Revenue Recognition Subtopic of the FASB ASC. The Company has entered into a contract whereby the Company has delivered certain elements and VSOE of fair value of the undelivered elements did not exist. As of June 30, 2010, the Company has recorded approximately $1.6 million of deferred revenue, net of deferred costs of $677,000, which is included in “accounts payable and accrued liabilities” in the condensed consolidated balance sheet.
For contract research and development arrangements that contain up-front or milestone-based payments, the Company recognizes revenue using the proportional performance method based on the percentage of costs incurred relative to the total costs estimated to be incurred to complete the contract. Revenue recognition computed under this methodology is compared with the amount of non-refundable cash payments received or contractually receivable at the reporting date and the lesser of the two amounts is recognized as revenue at each reporting date. The proportional performance methodology applied by the Company utilizes an input based measure, specifically costs incurred to date, to determine proportional performance because the Company believes the use of an input measure is a reasonable surrogate of proportional performance compared to an output based measure, such as milestones. Amounts billed in advance are recorded as deferred revenue, which is included in “accounts payable and accrued liabilities” in the condensed consolidated balance sheet. Since payments received are generally non-refundable, the termination of a contract by a customer prior to its completion could result in an immediate recognition of deferred revenue relating to payments already received but not previously recognized as revenue.
Foreign Currency Derivative Instruments
As part of its risk management strategy, Maxwell uses forward contracts to hedge certain foreign currency exposures. Maxwell’s objective is to offset gains or losses resulting from these exposures with opposing gains or losses on the forward contracts, thereby reducing volatility of earnings created by these foreign currency exposures. In accordance with the Derivatives and Hedging Topic of the FASB ASC, the fair values of the forward contracts are estimated based on quoted market prices and all forward contracts are recorded in “prepaid expenses and other current assets” or “accounts payable and accrued liabilities” on the condensed consolidated balance sheet at fair value. Any gains or losses recognized on these contracts are recorded in “cost of sales” and “selling, general and administrative” expense on the condensed consolidated statement of operations.
 
8

Table of Contents
Comprehensive Loss
The components of comprehensive loss are as follows (in thousands):

 	  	Three Months Ended
June 30,	 	 	Six Months Ended
June 30,	 	
 	  	2010	 	 	2009	 	 	2010	 	 	2009	 	
Net loss as reported	  	$	(2,584	) 	 	$	(5,335	) 	 	$	(1,342	) 	 	$	(8,300	) 	
Foreign currency translation adjustment	  	 	(920	) 	 	 	1,836	  	 	 	(1,770	) 	 	 	(661	) 	
Unrealized gain on securities	  	 	—  	  	 	 	—  	  	 	 	2	  	 	 	—  	  	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Comprehensive loss	  	$	(3,504	) 	 	$	(3,499	) 	 	$	(3,110	) 	 	$	(8,961	) 	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Computation of Net Loss per Share
In accordance with the Earnings Per Share Topic of the FASB ASC, basic loss per share is calculated using the weighted average number of common shares outstanding. Potentially dilutive securities are not considered in the calculation of net loss per share, as their inclusion would be anti-dilutive. The following table sets forth the computation of basic and diluted loss per share (in thousands, except per share data):

 	  	Three Months Ended
June 30,	 	 	Six Months Ended
June 30,	 	
 	  	2010	 	 	2009	 	 	2010	 	 	2009	 	
Numerator	  				 				 				 				
Net loss	  	$	(2,584	) 	 	$	(5,335	) 	 	$	(1,342	) 	 	$	(8,300	) 	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Denominator	  				 				 				 				
Weighted average common shares outstanding – basic and diluted	  	 	26,155	  	 	 	23,862	  	 	 	26,125	  	 	 	23,108	  	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net loss per share	  				 				 				 				
Basic and diluted	  	$	(0.10	) 	 	$	(0.22	) 	 	$	(0.05	) 	 	$	(0.36	) 	
The following table summarizes instruments that may be convertible into common shares that are not included in the denominator used in the diluted net loss per share calculation because to do so would be antidilutive (in thousands):

 	  	June 30,	
Common Stock	  	2010	  	2009	
Outstanding options to purchase common stock	  	1,776	  	1,679	
Restricted stock awards outstanding	  	234	  	399	
Shares issuable on conversion of convertible debentures	  	514	  	685	
Warrants to purchase common stock	  	462	  	462	
Restricted stock unit awards	  	8	  	11	
Income Tax Provision
The effective tax rate differs from the statutory U.S. federal income tax rate of 35% primarily due to foreign income tax and the valuation allowance against the Company’s domestic deferred tax assets.
Pending Accounting Pronouncements
In January 2010, the FASB issued ASU 2010-06, Fair Value Measurements and Disclosures , to improve the disclosures about fair value measurements. This update requires the Company to disclose separately the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and describe the reasons for the transfers. In the reconciliation for fair value measurements using significant unobservable inputs (Level 3), the Company will be required to present separately information about purchases, sales, issuances and settlements (that is, on a gross basis rather than as one net number). This update provides clarification as to the level of disaggregation in determining the appropriate classes of assets and liabilities. This update clarifies disclosures about inputs and valuation techniques for Level 2 and Level 3 fair value measurements. The new disclosures and clarifications of existing disclosures are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010, and for interim periods within those fiscal years. As this update is only disclosure-related, it does not have an impact on the Company’s financial position and results of operations.
In October 2009, the FASB reached a consensus on ASU 2009-13, Multiple-Deliverable Revenue Arrangements , and ASU 2009-14, Certain Revenue Arrangements That Include Software Elements . ASU 2009-13 modifies the requirements that must be met
 
9

Table of Contents
for an entity to recognize revenue from the sale of a delivered item that is part of a multiple-element arrangement when other items have not yet been delivered. ASU 2009-13 eliminates the requirement that all undelivered elements must have either: i) VSOE or ii) third-party evidence (“TPE”) before an entity can recognize the portion of an overall arrangement consideration that is attributable to items that already have been delivered. In the absence of VSOE or TPE of the standalone selling price for one or more delivered or undelivered elements in a multiple-element arrangement, entities will be required to estimate the selling prices of those elements. Overall arrangement consideration will be allocated to each element (both delivered and undelivered items) based on their relative selling prices, regardless of whether those selling prices are evidenced by VSOE or TPE or are based on the entity’s estimated selling price. The residual method of allocating arrangement consideration has been eliminated. ASU 2009-14 modifies the software revenue recognition guidance to exclude from its scope tangible products that contain both software and non-software components that function together to deliver a product’s essential functionality. These new updates are effective for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. Early adoption is permitted. This new pronouncement allows the Company to recognize revenue on multiple-deliverable arrangements earlier than in previous years. Although the Company is unable to estimate what those amounts will be in the future, the amounts recognized for multiple-deliverable revenue arrangements were approximately zero dollars and $896,000 for the years ended December 31, 2009 and 2008, respectively. As of June 30, 2010 and December 31, 2009, there was approximately $1.6 million and $1.9 million, respectively, of deferred revenue related to multiple-deliverable revenue arrangements.
Note 2 – Balance Sheet Details
Inventories
Inventories are stated at the lower of cost (on a first-in, first-out basis) or market. Finished goods and work-in-process inventory values include the cost of raw materials, labor and manufacturing overhead. The manufacturing overhead rate is calculated based on normal capacity. Inventory written down to market establishes a new cost basis and its value cannot be subsequently increased based upon changes in underlying facts and circumstances. Inventory consists of the following (in thousands):

 	  	June 30,
2010	 	 	December 31,
2009	 	
Inventories:	  				 				
Raw material and purchased parts	  	$	9,470	  	 	$	10,190	  	
Work-in-process	  	 	3,860	  	 	 	3,685	  	
Finished goods	  	 	7,257	  	 	 	6,555	  	
Inventory reserve	  	 	(2,779	) 	 	 	(2,642	) 	
	  	 	 	 	 	 	 	 	
Net inventory	  	$	17,808	  	 	$	17,788	  	
	  	 	 	 	 	 	 	 	
Intangible Assets
Intangible assets consisted of the following (in thousands):

 	  	Gross
Carrying
Value	  	Accumulated
Amortization	 	 	Foreign
Currency
Adjustment	 	 	Net
Carrying
Value	
As of June 30, 2010:	  			  				 				 			
Patents	  	$	2,476	  	$	(1,395	) 	 	$	—  	  	 	$	1,081	
Developed core technology	  	 	1,100	  	 	(1,078	) 	 	 	274	  	 	 	296	
Patent license agreement	  	 	741	  	 	(264	) 	 	 	(45	) 	 	 	432	
	  	 	 	  	 	 	 	 	 	 	 	 	 	 	
Total intangible assets at June 30, 2010	  	$	4,317	  	$	(2,737	) 	 	$	229	  	 	$	1,809	

 	  	Gross
Carrying
Value	  	Accumulated
Amortization	 	 	Foreign
Currency
Adjustment	 	 	Net
Carrying
Value	
As of December 31, 2009:	  			  				 				 			
Patents	  	$	3,276	  	$	(1,263	) 	 	$	—  	  	 	$	2,013	
Developed core technology	  	 	1,100	  	 	(1,002	) 	 	 	288	  	 	 	386	
Patent license agreement	  	 	741	  	 	(194	) 	 	 	(24	) 	 	 	523	
	  	 	 	  	 	 	 	 	 	 	 	 	 	 	
Total intangible assets at December 31, 2009	  	$	5,117	  	$	(2,459	) 	 	$	264	  	 	$	2,922	
	  	 	 	  	 	 	 	 	 	 	 	 	 	 	
Goodwill
The change in the carrying amount of goodwill from December 31, 2009 to June 30, 2010 is as follows (in thousands):
 
10

Table of Contents

Balance at December 31, 2009	  	$	22,799	  	
Foreign currency translation adjustments	  	 	(783	) 	
	  	 	 	 	
Balance at June 30, 2010	  	$	22,016	  	
	  	 	 	 	
Warranty Reserve
The Company provides product warranties in conjunction with certain product sales. The majority of the Company’s warranties are for one to two years in the normal course of business. The Company accrues for the estimated warranty at the time of sale based on historical warranty expenses, as well as any known or expected warranty exposure.
The following table sets forth an analysis of the warranty reserve activity for the six months ended June 30, 2010 and 2009, as follows (in thousands):

 	  	Six Months Ended June 30,	 	
Accrued Warranty:	  	    2010    	 	 	    2009    	 	
Beginning balance	  	$	588	  	 	$	905	  	
Product warranty expense on sales	  	 	367	  	 	 	225	  	
Charge to prior warranty expense/accrual	  	 	(14	) 	 	 	(51	) 	
Settlement of warranties	  	 	(421	) 	 	 	(162	) 	
Foreign currency translation adjustment	  	 	(19	) 	 	 	(52	) 	
	  	 	 	 	 	 	 	 	
Ending balance	  	$	501	  	 	$	865	  	
	  	 	 	 	 	 	 	 	
Change in Additional Paid in Capital
For the six months ended June 30, 2010, additional paid in capital increased $1.7 million, due to $1.9 million associated with the Company’s stock-based compensation plans, offset by $121,000 for the retirement of shares.
Note 3 – Fair Value Measurement
The convertible debentures (the “Debenture”) issued on December 20, 2005 were evaluated and determined not to be conventional convertible debentures and, therefore, because of certain terms and provisions including liquidating damages under the associated registration rights agreement the embedded conversion option was bifurcated and has been accounted for as a derivative liability instrument. The stock warrants issued on December 20, 2005 in conjunction with the convertible debt were also evaluated and determined to be a derivative instrument and, therefore, are classified as a liability on the balance sheet. The accounting guidance also requires that the conversion feature and warrants be recorded at fair value at each reporting period with changes in fair value recorded in the statement of operations. The fair value of the embedded conversion options and stock warrants are based on a Black-Scholes fair value calculation. The carrying value and fair value of the convertible debenture was approximately $8.3 million and $7.9 million, respectively, as of June 30, 2010. The fair value of the convertible debentures was based on the discounted cash flows of principal and interest payments using an interest rate of 5.88%.
The carrying value of restricted cash and short-term borrowings approximates fair value because the short maturity of these instruments.
The Company records certain assets and liabilities at fair value in accordance with the Fair Value Measurements and Disclosures Topic of the FASB ASC. As of June 30, 2010, the financial instruments to which this Topic applied were financial liabilities for the conversion feature of the convertible debenture, warrants and foreign currency forward contracts.
The foreign currency forward contracts are valued using quoted market prices. As of June 30, 2010, the fair value of foreign currency derivative instruments was nominal.
Liabilities measured at fair value on a recurring basis are summarized as follows (in thousands):

 	  	Fair Value Measurements as of
June 30, 2010	
Description	  	Total	  	Level 1	  	Level 2	  	Level 3	
Conversion features of convertible debenture	  	$	775	  	—  	  	—  	  	$	775	
Warrants	  	 	239	  	—  	  	—  	  	 	239	
For those financial instruments with significant Level 3 inputs, the following table summarizes the activity for the period by investment type (in thousands):
 
11

Table of Contents

Description	  	Convertible 1
 Debenture	 	 	Warrants 1	 	
Beginning liability balance, December 31, 2009	  	$	3,024	  	 	$	2,465	  	
Total unrealized gain included in net loss	  	 	(2,249	) 	 	 	(2,226	) 	
	  	 	 	 	 	 	 	 	
Ending liability balance, June 30, 2010	  	$	775	  	 	$	239	  	

1	Refer to Note 4 – Convertible Debenture for the valuation model and unobservable data used to calculate the fair value of the conversion features of the convertible debenture and warrants issued by the Company.	
Note 4 – Convertible Debenture
Maxwell accounts for the conversion option in the Debenture and the associated warrants as derivative liabilities in accordance with the Derivatives and Hedging Topic of the FASB ASC. The Debenture was issued on December 20, 2005 for $25 million in aggregate principal of senior subordinated convertible debt, due and payable in quarterly installments of $2.8 million beginning December 2007 through December 2009. However, the holder, at its election, could defer each quarterly payment one time, for a 24 month period. As the holder elected to defer some quarterly installments, the outstanding principal of the Debenture at June 30, 2010 was $8.3 million; this amount is payable with equal installments in June, September and December 2011.
The discount at the issuance date attributable to the aggregate fair value of the conversion options and warrants and the issuance costs totaling $9.2 million, are being amortized using the effective interest method over the term of the Debenture. For the three months ended June 30, 2010 and 2009, $20,000 and $243,000, respectively, and $41,000 and $622,000 for the six months ended June 30, 2010 and 2009, respectively, of the discount and prepaid fees was amortized and included in the condensed consolidated statement of operations.
Interest is due quarterly with the interest rate tied to the Federal Funds Rate plus 1.125% per annum. All or a portion of the accrued and unpaid interest may be paid in shares of Maxwell’s common stock at the Company’s option. As of June 30, 2010 and December 31, 2009, the interest rate on the Debenture was 1.375%. At June 30, 2010 and December 31, 2009 accrued interest on the Debenture was $29,000 and $34,000, respectively.
The following table summarizes principal and interest incurred on the Debenture for the three and six months ended June 30, 2010 and 2009, respectively (in thousands):

 	  	Three Months Ended
June 30, 2010	  	Three Months Ended
June 30, 2009	
Interest paid with cash	  	$	28	  	$	46	
	  	 	 	  	 	 	
Total Debenture interest payments	  	$	28	  	$	46	

 
											
 	  	Six Months Ended
June 30, 2010	  	Six Months Ended
June 30, 2009	
 	  	Value	  	Shares	  	Value	  	Shares	
Principal paid with cash	  	$	—  	  	—  	  	$	2,778	  	—  	
Interest paid with cash	  	 	62	  	—  	  	 	46	  	—  	
Interest paid with shares of common stock	  	 	—  	  	—  	  	 	92	  	18	
	  	 	 	  	 	  	 	 	  	 	
Total Debenture payments	  	$	62	  	—  	  	$	2,916	  	18	
	  	 	 	  	 	  	 	 	  	 	
At June 30, 2010, the Debenture was convertible by the holder at any time into 513,845 shares of common stock. The Company also issued warrants in connection with the issuance of the Debenture. At June 30, 2010, a total of 462,461 warrants were outstanding, which had an exercise price of $16.22 per share. The warrants are exercisable at any time through December 20, 2010. The exercise price and the number of convertible shares and warrants have been adjusted from the originally issued amounts and continue to be subject to an adjustment upon certain events, such as the sale of equity securities by Maxwell at a price below the current exercise price.
Maxwell may require that a specified amount of the principal of the Debenture be converted if certain conditions are satisfied for a period of 20 consecutive trading days. To determine a fair value of this forced conversion the Company applies a Z factor, which is a theoretical measurement of the probability of this occurrence. The probability used as of June 30, 2010 and December 31, 2009 was 2.4% and 35.2%, respectively, for forced conversion of 50% of the conversion option at 135% of the original exercise price and 0.1% and 22.4%, respectively, for forced conversion of the remaining conversion option at 175% of the original exercise price. The original exercise price was $19.00 per share.
 
12

Table of Contents
The fair value of the warrants and embedded conversion options is estimated on the balance sheet date using the Black-Scholes valuation model with the following assumptions:

 	  	Convertible Shares	 	 	Warrants	 	
 	  	June 30,
2010	 	 	December 31,
2009	 	 	June 30,
2010	 	 	December 31,
2009	 	
Black-Scholes Assumptions:	  				 				 				 				
Conversion / exercise price	  	$	16.22	  	 	$	16.22	  	 	$	16.22	  	 	$	16.22	  	
Market price	  	$	11.40	  	 	$	17.84	  	 	$	11.40	  	 	$	17.84	  	
Expected dividends	  	 	—  	  	 	 	—  	  	 	 	—  	  	 	 	—  	  	
Expected volatility	  	 	57.7	% 	 	 	86.9	% 	 	 	56.3	% 	 	 	67.7	% 	
Average risk-free interest rate	  	 	0.39	% 	 	 	0.98	% 	 	 	0.22	% 	 	 	0.47	% 	
Expected term/life (in years)	  	 	1.2	  	 	 	1.7	  	 	 	0.5	  	 	 	1.0	  	
The change in fair value on revaluation of the Debenture conversion rights and warrant liabilities represents the difference between the fair value at the end of the current period and the fair value at the beginning of the current period using the value calculated by the Black-Scholes pricing model. The fair value of the warrants at June 30, 2010 and December 31, 2009 was $239,000 and $2.5 million, respectively and is included in “stock warrants” on the balance sheet. The net fair value of the liability for the holder’s and Maxwell’s conversion rights at June 30, 2010 and December 31, 2009 was $775,000 and $3.0 million, respectively, which is included in “convertible debenture and long-term debt” on the balance sheet. The effect of the fair market value adjustment for the three months ended June 30, 2010 and 2009 was a $1.2 million gain and a $3.8 million loss, respectively, and a $4.5 million gain and a $4.4 million loss for the six months ended June 30, 2010 and 2009, respectively. These adjustments are recorded as “gain (loss) on embedded derivative and warrants.”
In the event of any default or fundamental change as defined in the Debenture, the holder will be entitled to require Maxwell to redeem the Debenture (or any portion thereof) at a price equal to the greater of (i) the applicable redemption premium (ranging from 103%-115%) or (ii) the product of (x) the number of shares into which the Debenture is convertible using the $16.22 per share conversion price and (y) the closing price of Maxwell’s common stock on the day preceding the default or fundamental change.
The Company shall pay to each holder of registrable securities related to the embedded conversion feature and warrants liquidated damages of 1.5% of the aggregate purchase price every 30th day after a failure of the registration of the securities. These damages continue each 30 days (pro rated) until the registration failure is cured. As of June 30, 2010, if the Company was not in compliance it would have incurred damages of $238,000 every 30 days until the failure was cured. In addition, if the damages are not paid in 30 days after they are due the Company would incur interest of 1.0% per month on the outstanding damages.
As long as the Debenture is outstanding, the Company is required to maintain a cash balance of $8.0 million, which is classified as restricted cash at June 30, 2010 and December 31, 2009.
Note 5 – Foreign Currency Derivative Instruments
Maxwell uses forward contracts to hedge certain monetary assets and liabilities, primarily receivables and payables, denominated in a foreign currency. The change in fair value of these instruments represents a natural hedge as their gains and losses offset the changes in the underlying fair value of the monetary assets and liabilities due to movements in currency exchange rates. These contracts generally expire in one month. These contracts are considered economic hedges and are not designated as hedges under the Derivatives and Hedging Topic of the FASB ASC. Therefore, the change in the instrument’s fair value is recognized currently in earnings.
Gains (losses) on foreign currency forward contracts included in cost of sales and selling, general and administrative are (in thousands):

 	  	Three Months Ended
June 30,	  	Six Months Ended
June 30,	
 	  	2010	 	 	2009	  	2010	 	 	2009	
Gains (losses) on foreign currency forward contracts recognized:	  				 			  				 			
Cost of sales	  	$	87	  	 	$	—  	  	$	355	  	 	$	—  	
Selling, general and administrative	  	 	(81	) 	 	 	—  	  	 	(270	) 	 	 	—  	
	  	 	 	 	 	 	 	  	 	 	 	 	 	 	
Total	  	$	6	  	 	 	—  	  	$	85	  	 	 	—  	
	  	 	 	 	 	 	 	  	 	 	 	 	 	 	
As of June 30, 2010, the total notional amount of foreign currency forward contracts not designated as hedges was approximately $3.8 million. The fair value of these derivatives not designated as hedging instruments was nominal at June 30, 2010
 
13

Table of Contents
and is included in “prepaid expenses and other current assets” on the balance sheet. For additional information, refer to Note 3 – Fair Value Measurements.
The gains (losses) on foreign currency forward contracts were partially offset by gains (losses) on those underlying monetary assets and liabilities. Foreign currency transactions gains (losses) on those monetary assets and liabilities included in cost of sales and selling, general and administrative are (in thousands):

 	  	Three Months Ended
June 30,	  	Six Months Ended
June 30,	
 	  	2010	 	 	2009	  	2010	 	 	2009	
Cost of sales	  	$	(133	) 	 	$	—  	  	$	(304	) 	 	$	—  	
Selling, general and administrative	  	 	19	  	 	 	—  	  	 	169	  	 	 	—  	
	  	 	 	 	 	 	 	  	 	 	 	 	 	 	
Total	  	$	(114	) 	 	 	—  	  	$	(135	) 	 	 	—  	
	  	 	 	 	 	 	 	  	 	 	 	 	 	 	
Note 6 – Stock-Based Compensation
The Company has two active stock-based compensation plans as of June 30, 2010: the 2004 Employee Stock Purchase Plan (the “ESPP”) under which employees purchase common stock; and the 2005 Omnibus Equity Incentive Plan (the “Incentive Plan”) under which the Company may grant incentive stock options, non-qualified stock options, restricted stock awards and restricted stock units.
Employee Stock Options
Compensation expense recognized from employee stock options for the three months ended June 30, 2010 and 2009 was $384,000 and $287,000, respectively, and $800,000 and $595,000 for the six months ended June 30, 2010 and 2009, respectively. For the six months ended June 30, 2010 and 2009 the total employee stock options granted were 200,650 and 301,350, respectively, with an average grant date fair value per share of $9.09 and $4.06, respectively. The fair value of the stock options is estimated using the Black-Scholes valuation model with the following assumptions:

 	  	Six Months Ended
June 30,	 	
 	  	2010	 	 	2009	 	
Expected dividends	  	—  	  	 	—  	  	
Expected volatility	  	69.4	% 	 	69.0	% 	
Average risk-free interest rate	  	2.7	% 	 	1.8	% 	
Expected term/life (in years)	  	4.8	  	 	4.5	  	
Restricted Stock Awards
In accordance with the Stock Compensation Topic of the FASB ASC, the Company determines the fair value of restricted stock awards at the grant date and expenses that amount over the requisite service period. At each reporting period, the Company reassesses the probability of achievement of performance milestones for each restricted stock award and adjusts stock-based compensation expense based on the awards that are expected to vest. The following table summarizes the amount of compensation expense recognized for the three and six months ended June 30, 2010 and 2009 (in thousands):

 	  	Three Months Ended
June 30,	  	Six Months Ended
June 30,	
 	  	2010	  	2009	  	2010	 	 	2009	
Service based restricted stock	  	$	224	  	$	106	  	$	391	  	 	$	255	
Performance based restricted stock	  	 	70	  	 	336	  	 	(12	) 	 	 	486	
	  	 	 	  	 	 	  	 	 	 	 	 	 	
Total compensation expense recognized for restricted stock awards	  	$	294	  	$	442	  	$	379	  	 	$	741	
	  	 	 	  	 	 	  	 	 	 	 	 	 	
Employee Stock Purchase Plan
The ESPP permits substantially all employees to purchase common stock through payroll deductions at 85% of the lower of the trading price of the stock at the beginning or at the end of each six month offering period commencing on January 1 and July 1. The number of shares purchased is based on participants’ contributions made during the offering period.
The fair value of the ESPP shares to be granted during the offering period is estimated using the Black-Scholes valuation model for a call and a put option. Compensation expense recognized for the ESPP for the three months ended June 30, 2010 and 2009 was $15,000 and $62,000, respectively, and $87,000 and $143,000 for the six months ended June 30, 2010 and 2009, respectively. The share price used for the model is a 15% discount on the stock price on the first day of the offering period; the number of shares to be
 
14

Table of Contents
purchased is calculated based on employee contributions. The table below summarizes the assumptions used in valuing the ESPP shares:

 	  	For the offering period beginning January 1
and ending June 30,	 	
 	  	2010	 	 	2009	 	
Expected dividends	  	$	—  	  	 	$	—  	  	
Stock price on valuation date	  	 	17.84	  	 	 	5.07	  	
Expected volatility	  	 	53.3	% 	 	 	121.0	% 	
Average risk-free interest rate	  	 	0.20	% 	 	 	0.27	% 	
Expected life (in years)	  	 	0.5	  	 	 	0.5	  	
Fair value per share	  	$	5.35	  	 	$	2.43	  	
Restricted Stock Units
As of January 1, 2009, the non-employee directors of the Company were no longer paid a quarterly retainer in cash. Instead, the Company granted non-discretionary restricted stock unit (“RSU”) awards under the 2005 Omnibus Equity Incentive Plan.
On the last trading day of each calendar quarter, each non-employee director who has been a director for the full quarter will automatically receive an RSU award covering a number of shares of the Company’s common stock determined by dividing $6,250 by the closing selling price of the Company’s common stock on the last trading day of the calendar quarter. These quarterly RSU awards will be fully vested on the date of automatic grant. Each RSU award granted pursuant to this retainer program will be settled and shares issued thereunder on the earliest to occur of (i) February 15 of the calendar year following the calendar year in which granted, (ii) 60 days after the director’s service terminates or (iii) the occurrence of a change of control.
The Company determines the fair value at the grant date and expenses that amount immediately. Total compensation expense recognized for service based restricted stock unit awards was $50,000 during the three months ended June 30, 2010 and 2009 and $100,000 for the six months ended June 30, 2010 and 2009.
Stock-based Compensation Expense
Compensation cost for employee stock options, restricted stock awards, RSU awards and the ESPP included in cost of sales; selling, general and administrative; and research and development is (in thousands):

 	  	Three Months Ended
June 30,	  	Six Months Ended
June 30,	
 	  	2010	  	2009	  	2010	  	2009	
Stock-based compensation expense recognized:	  			  			  			  			
Cost of sales	  	$	89	  	$	101	  	$	205	  	$	203	
Selling, general and administrative	  	 	575	  	 	624	  	 	1,068	  	 	1,150	
Research and development	  	 	79	  	 	116	  	 	93	  	 	226	
	  	 	 	  	 	 	  	 	 	  	 	 	
Total stock-based compensation costs	  	$	743	  	$	841	  	$	1,366	  	$	1,579	
	  	 	 	  	 	 	  	 	 	  	 	 	
Note 7 – Commitments and Contingencies
The Company enters into indemnification agreements in the ordinary course of business in which the indemnified party is held harmless and is reimbursed for losses incurred from claims by third parties. In connection with divestitures of certain assets or businesses, the Company often provides indemnities to the buyer with respect to certain matters including, for example, environmental liabilities and unidentified liabilities related to periods prior to the disposition. Due to the uncertain nature of the indemnities, the maximum liability cannot be quantified. Liabilities for obligations are recorded where appropriate and when they are probable and can be reasonably estimated. Historically, the Company has not made significant payments for these obligations.
As a result of Maxwell’s international operations, the Company is subject to the U.S. Foreign Corrupt Practices Act (“FCPA”), which prohibits companies from making improper payments to foreign officials for the purpose of obtaining or keeping business. As a result of an internal review, the Company is currently conducting an inquiry into the nature of certain payments made to its former independent sales agent in China with respect to sales of its high voltage capacitor products produced by the Swiss subsidiary. These payments equaled the difference between Maxwell’s quoted price for certain products and the amount that the independent sales agent was able to sell such products to certain customers in China. These payments had previously been recorded as commissions; however, a portion of those payments may actually have been rebated directly or indirectly to customers. Maxwell recorded commissions to the agent of $585,000, $1.8 million and $653,000 for the years ended December 31, 2009, 2008 and 2007, respectively. These commissions were based on sales of $3.1 million, $8.2 million and $3.4 million for the years ended December 31, 2009, 2008 and 2007, respectively. These amounts were previously recorded as revenue and commission expense; however, they have been
 
15

Table of Contents
reclassified as a reduction to revenue for all periods presented. The Company terminated its relationship with this independent sales agent as of May 20, 2009.
Maxwell is in the process of evaluating how these payments should be treated for FCPA purposes. The Company’s internal review is focused on a thorough examination of all of its international operations and business practices, as well as a review of its compliance programs. The Company has taken certain remedial actions, including terminating its relationship with the independent sales agent in China as well as terminating its relationship with Metar SA, a former related party to the Company. The termination of these relationships and the ongoing investigation could harm the Company’s business.
Maxwell has not yet completed its internal review. As the Company progresses, management is voluntarily sharing information related to its internal review with the SEC and DOJ and has provided certain documents as requested by the SEC and DOJ in connection with their review of this matter. In the event that the Company’s internal review or any governmental investigation identifies violations of law, the DOJ, the SEC or other governmental authorities could seek civil and/or criminal sanctions, including monetary fines and penalties, against the Company and/or its employees, as well as additional changes to its business practices and compliance programs, which could have a material adverse effect on the Company’s business, results of operations and financial condition.
As previously disclosed, the Company has engaged in settlement discussions with the SEC and DOJ with regard to the ongoing FCPA investigations. The Company has negotiated an agreement in principle with the SEC to resolve the ongoing FCPA investigations for a payment of approximately $6.35 million in two installments, with half paid on signing and the remaining half upon the one year anniversary of the signing, as well as certain other settlement terms. The settlement with the SEC remains subject to final approval of the Commission. Settlement discussions with the DOJ are ongoing, and the Company has made an offer to the DOJ to settle the ongoing investigation for $6.35 million. The Company is awaiting a response from the DOJ to its most recent offer. As with all potential settlements with the DOJ, there are numerous other aspects of the settlement, in addition to the monetary penalties, that also need to be resolved. In the fourth quarter of 2009, the company accrued $9.3 million for a potential settlement, and has accrued an additional $3.4 million in the second quarter of 2010 to reflect the full amount of its pending settlement offers to the SEC and DOJ. However, there can be no assurance that the settlement with the SEC will be approved or that the Company will be able to settle with the DOJ for $6.35 million. Previous discussions with the SEC and DOJ have resulted in an estimate of potential settlement of up to $20.0 million – representing the combined first offer of settlement put forth by the SEC and DOJ. The total accrual as of June 30, 2010 of $12.7 million represents the Company’s assessment of the best estimate of settlement within the anticipated settlement range.
Note 8 – Legal Proceedings
There have been no material changes from the legal proceedings disclosed in Note 14 of the Notes to Consolidated Financial Statements included in Part II, Item 8 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 except the product defect and omega chemical matters described below.
Product Defect Matter
In 2005, a customer claimed a possible defect in a product that was produced for the Company under contract by another manufacturer, Epcos AG, and resold to the customer. In an effort to resolve the matter, the Company’s Swiss subsidiary, Maxwell SA, initiated a legal proceeding in Germany in late 2007 against the product manufacturer. The suit is currently in the discovery phase during which time the court appointed technical expert issued an opinion that: (a) a defect in a substantial number of the products existed; and (b) the defect is one stemming from manufacturing of the products and not from operating conditions of the end use system. Epcos AG has formally opposed the validity of the expert’s opinion, which is standard practice within this type of proceeding, and the expert is now expected to submit a follow up written opinion. The parties have plans to enter into settlement negotiations in the near term to allocate liability for the damages associated with the defective products. Since the matter is still in its preliminary stages and no quantified damages assertions have been formally made, the Company has not yet been able to determine what, if any, warranty exposure it may have, and therefore, has not recorded any warranty reserve provision. The Company does, however, carry insurance that may cover a portion of such warranty liability that might ultimately arise from this matter.
 
16

Table of Contents
Omega Chemical
In August 2009, unrelated to the Angeles Chemical matter and yet pertaining to the original Omega Chemical matter, the Omega PRP Organized Group (OPOG) submitted a good faith offer letter to parties who settled their portion of the Omega matter for 100% of their respective liabilities for the original Omega Chemical clean up efforts. Within the offer letter, OPOG solicited additional funding for additional clean up efforts it claims are necessary to remediate the Omega Chemical site. Maxwell has joined several other parties receiving the same good faith offer letter from OPOG to review and assess the validity of OPOG’s claim for further clean up funding. To review the state of the Omega Chemical site and assist in determining the validity of such claims, including cost estimates, these collaborating parties hired an outside consultant, made by OPOG and submitted a counter offer to OPOG in accordance with the consultant’s recommendations which identifies Maxwell’s liability in the amount of $48,000. In July, OPOG submitted an additional counter offer which allocates Maxwell’s liability in the amount of $136,000 and includes a conditional indemnification for both the Omega Chemical matter and the Angeles Chemical matter along with any additional matters pertaining to activities stemming from the Omega site. The total accrual for this matter as of June 30, 2010 is $136,000, based on the additional counter offer.
Note 9 – Defined Benefit Plan
Maxwell SA, a subsidiary of the Company, has a retirement plan that is classified as a defined benefit pension plan. The pension benefit is based on compensation, length of service and credited investment earnings. The plan guarantees both a minimum rate of return as well as minimum annuity purchase rates. The Company’s funding policy with respect to the pension plan is to contribute, at a minimum, the amount required by Swiss law, using the required percentage applied to the employee’s compensation. In addition, the employee is required to contribute to the pension plan. This plan has a measurement date of December 31.
Components of the net periodic benefit (cost) were as follows (in thousands):

 	  	Three Months
Ended June 30,	 	 	Six Months
Ended June 30,	 	
 	  	2010	 	 	2009	 	 	2010	 	 	2009	 	
Service cost	  	$	(148	) 	 	$	(168	) 	 	$	(303	) 	 	$	(331	) 	
Interest cost	  	 	(144	) 	 	 	(153	) 	 	 	(295	) 	 	 	(302	) 	
Expected return on plan assets	  	 	350	  	 	 	315	  	 	 	717	  	 	 	622	  	
Prior service cost amortization	  	 	(9	) 	 	 	(9	) 	 	 	(19	) 	 	 	(18	) 	
Net gain amortization	  	 	—  	  	 	 	(89	) 	 	 	—  	  	 	 	(175	) 	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net periodic benefit (cost)	  	$	49	  	 	$	(104	) 	 	$	100	  	 	$	(204	) 	
	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Employer contributions of $149,000 and $139,000 were paid during the three months ended June 30, 2010 and 2009, respectively. Total employer contributions of $308,000 and $278,000 were paid during the six months ended June 30, 2010 and 2009, respectively. Additional employer contributions of approximately $302,000 are expected to be paid during the remainder of fiscal 2010.
Note 10 – Related Party
Maxwell SA’s pension plan has provided a long term loan of 700,000 Swiss Francs (approximately $650,000 as of June 30, 2010) to Montena Properties SA. Montena Properties SA is 100% owned by Montena SA. The loan has been renegotiated to be repaid in full by or before November 15, 2011 and bears an interest rate of 4.5%. A member of Maxwell Technologies, Inc’s Board of Directors, José Cortes, is also the Chairman of the Board of Montena SA, as well as an indirect minority stockholder. The loan was provided to Montena Properties SA prior to Mr. Cortes becoming a director of Maxwell.
 
17

Table of Contents

 Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	
Unless the context otherwise requires, all references in this Quarterly Report on Form 10-Q (this “Quarterly Report”) to “Maxwell,” the “Company,” “we,” “us,” and “our” refer to Maxwell Technologies, Inc. and its subsidiaries; all references to “Maxwell SA” refer to our European subsidiary, Maxwell Technologies, SA.
FORWARD-LOOKING STATEMENTS
Some of the statements contained in this document and incorporated herein by reference discuss our plans and strategies for our business or make other forward-looking statements, as this term is defined in the Private Securities Litigation Reform Act. The words “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “may,” “could,” “will,” “continue,” “seek,” “should,” “would” and similar expressions are intended to identify these forward-looking statements, but are not the exclusive means of identifying them. These forward-looking statements reflect the current views and beliefs of our management; however, various risks, uncertainties and contingencies could cause our actual results, performance or achievements to differ materially from those expressed in, or implied by, our statements. Such risks, uncertainties and contingencies include, but are not limited to, the following:
 
 	•	 	financial markets disruption, including, among other things, volatility in securities prices and diminished liquidity and credit availability;	
 
 	•	 	decline in the domestic and global economies that may delay development and introduction of new products by our customers;	
 
 	•	 	our success in introducing and marketing new products into existing and new markets;	
 
 	•	 	our ability to manufacture existing and new products in volumes demanded by our customers and at competitive prices with adequate gross margins;	
 
 	•	 	market success of the products into which our products are integrated;	
 
 	•	 	the timing and success of new product introductions by third parties into which our products are integrated;	
 
 	•	 	our ability in growing markets to increase our market share relative to our competitors;	
 
 	•	 	our ability to successfully integrate our business with operations of businesses we may acquire;	
 
 	•	 	our ability to finance the growth of our business with internal resources or through outside equity or debt financing on reasonable terms or at reasonable rates; and	
 
 	•	 	our ability to produce our products at quality levels demanded by our customers.	
Many of these factors are beyond our control. Additionally, there can be no assurance that we will not incur new or additional unforeseen costs in connection with the ongoing conduct of our business. Accordingly, any forward-looking statements included herein do not purport to be predictions of future events or circumstances and may not be realized.
For a discussion of important risks associated with an investment in our securities, including factors that could cause actual results to differ materially from expectations referred to in the forward-looking statements, see Risk Factors in Part II, Item 1A, of this document and Part I, Item 1A, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009. We do not have any obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
Executive Summary
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of our financial statements with a narrative from the perspective of our management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. Our MD&A is presented in the following sections:
 
 	•	 	Overview	
 
 	•	 	Highlights of the Six Months Ended June 30, 2010	
 
 	•	 	Results of Operations	
 
 	•	 	Liquidity and Capital Resources	
 
 	•	 	Critical Accounting Policies and Estimates	
 
 	•	 	Pending Accounting Pronouncements	
 
 	•	 	Off Balance Sheet Arrangements	
 
18

Table of Contents
Overview
Maxwell Technologies, Inc. is a Delaware corporation that is headquartered in San Diego, California. We originally incorporated in 1965 under the name Maxwell Laboratories, Inc. In 1996, we changed our name to Maxwell Technologies, Inc. We develop, manufacture and market energy storage and power delivery products for transportation, industrial telecommunications and other applications and microelectronic products for space and satellite applications.
Maxwell has two manufacturing locations (San Diego, California and Rossens, Switzerland). In addition, we have two contract manufacturers in Shenzhen, China and Tianjin, China. Maxwell operates as one operating segment called High Reliability, which is comprised of three product lines:
 
 	•	 	Ultracapacitors: Our primary focus is on ultracapacitors, energy storage devices that possess a unique combination of high power density, long operational life and the ability to charge and discharge very rapidly. Our BOOSTCAP ® ultracapacitor cells and multi-cell modules provide highly reliable energy storage and power delivery solutions for applications in multiple industries, including transportation, automotive, telecommunications, renewable energy and consumer and industrial electronics.	
 
 	•	 	High-Voltage Capacitors: Our CONDIS ® high-voltage capacitors are designed and manufactured to perform reliably for decades in all climates. These products include grading and coupling capacitors and capacitive voltage dividers that are used to ensure the safety and reliability of electric utility infrastructure and other applications involving transport, distribution and measurement of high-voltage electrical energy.	
 
 	•	 	Radiation-Mitigated Microelectronic Products: Our radiation-mitigated microelectronic products include high-performance, high-density power modules, memory modules and single board computers that incorporate our proprietary RADPAK ® packaging and shielding technology and novel architectures that enable them to withstand the effects of environmental radiation and perform reliably in space.	
Our goal is to meet or exceed the life of the application product and service needs of our customers through continuous improvements of the effectiveness of all our business processes. We aim to design and manufacture our products to perform reliably for the life of the products and systems into which they are integrated. We seek to achieve high reliability through the application of proprietary technologies and rigorously controlled design, development, manufacturing and test processes. This high reliability strategy emphasizes the development and marketing of products that could enable us to achieve higher profit margins than commodity electronic components and systems.
Highlights of the Six Months Ended June 30, 2010
We reported revenue of $29.6 million and a net loss of $2.6 million, or $0.10 per diluted share, for the second quarter of 2010; compared with revenue of $24.8 million and a net loss of $5.3 million, or $0.22 per diluted share, for the same quarter in 2009. We reported revenue of $56.2 million and a net loss of $1.3 million, or $0.05 per diluted share, for the six months ended June 30, 2010; compared with revenue of $47.2 million and a net loss of $8.3 million, or $0.36 per diluted share, for the six months ended June 30, 2009.
During the six months ended June 30, 2010, we continued to focus on developing strategic alliances, introducing new products, increasing production capacity to meet anticipated future demand, reducing product costs, capital investments to facilitate growth, augmenting executive management and improving production processes. Some of these efforts are described below:
 
 	•	 	In May, we announced that Robert L. Guyett had been elected chairman of the company’s board of directors. Guyett, 73, joined Maxwell’s board in January 2000, and previously served as chairman from May 2003 through May 2007. He also chairs the board’s Audit Committee and serves on the Compensation and Governance, Nominating and Strategy Committees. Since 1995, he has been President and Chief Executive Officer of Crescent Management Enterprises LLC, a consulting firm that provides financial management and investment advisory services. He is a director of Newport Corp., a NASDAQ-listed supplier of products and systems to the semiconductor, communications, electronics, research and life science markets. He also serves on the boards of privately held companies and is a director and treasurer of the Christopher and Dana Reeve Foundation. Earlier in his career, he was a director and chief financial officer of Engelhard Corp. and before that was a director and chief financial officer of Fluor Corporation.	
 
 	•	 	In May, we announced an agreement with Rutronik Elektronische Bauelemente GmbH through which Rutronik will distribute Maxwell’s BOOSTCAP ® ultracapacitor products throughout Europe. Under this new contract, Rutronik will especially address the European industrial, automotive, renewable energies and other key energy storage market segments with Maxwell’s ultracapacitor products.	
 
 	•	 	In March, we announced that capacity expansion and process improvements in our production facility will position our CONDIS ® family of high voltage capacitor products to support a potential growth in sales.	
 
19

Table of Contents

 	•	 	In March, we announced that Voith Turbo, a leading producer of heavy vehicle drive systems, had selected Maxwell’s 125-volt Boostcap ® ultracapacitor modules for braking energy recuperation and torque assist in low-emission, fuel-efficient, hybrid-electric transit bus drive systems. Voith and Maxwell have entered into a strategic supply agreement through which Maxwell is Voith’s exclusive supplier of ultracapacitor modules assembled in the United States to meet local content requirements.	
 
 	•	 	In February, we introduced and began shipping our new K2 Series large cell Boostcap ® ultracapacitors. The K2 series Boostcap ® cells operate at 2.7 volts and incorporate design and construction enhancements to ensure high performance, durability and long operating lifetime. This design advancement allowed us to improve the performance of our large cell ultracapacitor product line, while maintaining the same form and function as well as reducing the cost of the product.	
 
 	•	 	In February, we announced the realignment and expansion of our executive team reflecting the increased focus we are placing on product development, marketing and business development to strengthen and expand our presence in the marketplace. We changed the scope of vice president Michael Liedtke’s responsibilities to business development, market intelligence and strategic planning, appointed Van M. Andrews vice president, ultracapacitor sales and marketing and promoted Jeremy Cowperthwaite to the newly created position of vice president, ultracapacitor engineering.	
Results of Operations
The Second Quarter of 2010 Compared with the Second Quarter of 2009
The following table presents certain unaudited statement of operations data expressed as a percentage of revenue for the periods indicated:

 	  	Quarter Ended
June 30,	 	
 	  	2010	 	 	2009	 	
Revenue	  	100	% 	 	100	% 	
Cost of sales	  	60	% 	 	64	% 	
	  	 	 	 	 	 	
Gross profit	  	40	% 	 	36	% 	
Operating expenses:	  			 			
Selling, general and administrative	  	38	% 	 	23	% 	
Research and development	  	13	% 	 	17	% 	
	  	 	 	 	 	 	
Total operating expenses	  	51	% 	 	40	% 	
	  	 	 	 	 	 	
Loss from operations	  	(11	)% 	 	(4	)% 	
Other expense, net	  	4	% 	 	(16	)% 	
	  	 	 	 	 	 	
Loss from continuing operations before income taxes	  	(7	)% 	 	(20	)% 	
Income tax provision	  	2	% 	 	2	% 	
	  	 	 	 	 	 	
Net loss	  	(9	)% 	 	(22	)% 	
	  	 	 	 	 	 	
Our net loss for the second quarter of 2010 improved $2.8 million compared with the same quarter one year ago. Our net loss reported in the current quarter was $2.6 million, or $0.10 per diluted share, compared with a net loss of $5.3 million, or $0.22 per diluted share, in the same quarter one year ago. The net loss comparison is affected by a $3.4 million additional accrual in the second quarter of 2010 for the potential settlement of alleged U.S. Foreign Corrupt Practices Act (“FCPA”) violations and a gain on embedded derivative and warrants of $1.2 million in the second quarter of 2010 compared with a loss on embedded derivative and warrants of $3.8 million in the same quarter one year ago. Excluding the settlement accrual and the gain or loss on embedded derivative and warrants, our net loss for the second quarter of 2010 improved by $1.1 million compared with the same period one year ago, driven primarily by an increase in revenues combined with an improvement in gross profit. More specifics of these areas are discussed below.
 
20

Table of Contents
Revenue and Gross Profit
The following table presents a comparison of revenue, cost of sales and gross profit for the quarters ended June 30, 2010 and 2009 (in thousands, except percentages):

 	  	Quarter Ended
June 30, 2010	 	 	Quarter Ended
June 30, 2009	 	 	 	  	 	 	
 	  	Amount	  	% of
Net
Revenue	 	 	Amount	  	% of
Net
Revenue	 	 	Increase	  	%
Change	 	
Revenue	  	$	29,579	  	100	% 	 	$	24,754	  	100	% 	 	$	4,825	  	19	% 	
Cost of sales	  	 	17,742	  	60	% 	 	 	15,839	  	64	% 	 	 	1,903	  	12	% 	
	  	 	 	  	 	 	 	 	 	  	 	 	 	 	 	  	 	 	
Gross profit	  	$	11,837	  	40	% 	 	$	8,915	  	36	% 	 	$	2,922	  	33	% 	
	  	 	 	  	 	 	 	 	 	  	 	 	 	 	 	  	 	 	
Revenue. In the second quarter of 2010, revenue increased 19% to $29.6 million, compared with $24.8 million in the same quarter one year ago. Ultracapacitor revenue increased by 48%, to $15.9 million in the second quarter of 2010, compared with $10.7 million in the same quarter one year ago. Sales of high voltage capacitor and microelectronics products totaled $13.7 million in the second quarter of 2010, down 2% from the $14.0 million recorded in the same quarter one year ago. The increase in revenue from our ultracapacitor product line was influenced primarily by continuing strong demand for energy storage and power delivery systems for wind turbines, hybrid transit buses and backup power.
A substantial amount of our revenue is generated through our Swiss subsidiary. As such, reported revenue can be materially impacted by the changes in exchange rates between the Swiss Franc and the U.S. dollar, our reporting currency. Since the quarterly weighted average of the U.S. Dollar against the Swiss Franc during the second quarter of 2010 was $0.8956 per Swiss Franc compared with $0.8984 per Swiss Franc in the same period one year ago, there was little impact from exchange rates when comparing the second quarter of 2010 to the same quarter in 2009.
Gross Profit. In the second quarter of 2010, gross profit increased $2.9 million or 33% compared with the same quarter one year ago. As a percentage of revenue, gross profit increased to 40% compared with 36% in the same period one year ago. Higher gross profit resulted primarily from $1.7 million due to an increase in revenue volume and $1.2 million in net reductions of product costs. Product cost reductions were driven primarily by advancements in our manufacturing process and product design. The product design advancements allowed us to reduce  product cost while improving the performance of our large cell ultracapacitor product line.
Selling, General & Administrative (SG&A) Expense
The following table presents a comparison of selling, general and administrative expense for the second quarter of 2010 and 2009 (in thousands, except percentages):

 	  	Quarter Ended
June 30, 2010	 	 	Quarter Ended
June 30, 2009	 	 	 	  	 	 	
 	  	Amount	  	% of
Net
Revenue	 	 	Amount	  	% of
Net
Revenue	 	 	Increase	  	%
Change	 	
Selling, general and administrative	  	$	11,164	  	38	% 	 	$	5,628	  	23	% 	 	$	5,536	  	98	% 	
SG&A expenses were 38% of revenue for second quarter of 2010, up from 23% in the same quarter one year ago, and total expenses increased $5.5 million, or 98%, from the same quarter one year ago. The increase in absolute dollars was driven primarily by a $3.4 million additional accrual for the potential settlement of alleged FCPA violations and approximately $1.1 million in net foreign exchange transaction losses in the second quarter of 2010 compared with approximately $400,000 in net foreign exchange transaction gains in the same quarter one year ago. The foreign exchange transaction losses were driven by the weakening of the Euro against the U.S. Dollar and Swiss Franc.
 
21

Table of Contents
Research & Development (R&D) Expense
The following table presents a comparison of research and development expense for the second quarter of 2010 and 2009 (in thousands, except percentages):

 	  	Quarter Ended
June 30, 2010	 	 	Quarter Ended
June 30, 2009	 	 	 	 	  	 	 	
 	  	Amount	  	% of
Net
Revenue	 	 	Amount	  	% of
Net
Revenue	 	 	Increase	 	  	%
Change	 	
Research and development	  	$	3,954	  	13	% 	 	$	4,098	  	17	% 	 	$	(144	) 	  	(4	)% 	
R&D expenses were 13% of revenue for the second quarter of 2010, compared with 17% from the same quarter one year ago, and total expenses decreased by $144,000, or 4%. The decrease in absolute dollars was driven primarily by decreases in the cost of inventory and other materials used for product development.
Provision for Income Taxes
We recorded an income tax provision of $410,000 for the second quarter of 2010 compared with $319,000 for the same quarter in 2009. This provision is related to taxes on income generated by our Swiss subsidiary. Unremitted earnings of foreign subsidiaries have been included in the consolidated financial statements without giving effect to the United States taxes that may be payable as it is not anticipated such earnings will be remitted to the United States.
The Six Months Ended June 30, 2010 Compared with the Six Months Ended June 30, 2009
The following table presents certain unaudited statement of operations data expressed as a percentage of revenue for the periods indicated:

 	  	Six Months Ended
June 30,	 	
 	  	2010	 	 	2009	 	
Revenue	  	100	% 	 	100	% 	
Cost of sales	  	61	% 	 	66	% 	
	  	 	 	 	 	 	
Gross profit	  	39	% 	 	34	% 	
Operating expenses:	  			 			
Selling, general and administrative	  	33	% 	 	23	% 	
Research and development	  	15	% 	 	17	% 	
	  	 	 	 	 	 	
Total operating expenses	  	48	% 	 	40	% 	
	  	 	 	 	 	 	
Loss from operations	  	(9	)% 	 	(6	)% 	
Other income (expense), net	  	8	% 	 	(11	)% 	
	  	 	 	 	 	 	
Loss from continuing operations before income taxes	  	(1	)% 	 	(17	)% 	
Income tax provision	  	1	% 	 	1	% 	
	  	 	 	 	 	 	
Net income (loss)	  	(2	)% 	 	(18	)% 	
	  	 	 	 	 	 	
Our net loss for the six months ended June 30, 2010 improved $7.0 million compared with the same period one year ago. Our net loss for the six months ended June 30, 2010 was $1.3 million, or $0.05 per diluted share, compared with a net loss of $8.3 million, or $0.36 per diluted share, in the same period one year ago. The net loss comparison is affected by a $3.4 million additional accrual in the second quarter of 2010 for the potential settlement of alleged FCPA violations and a gain on embedded derivative and warrants of $4.5 million for the six months ended June 30, 2010, compared with a loss on embedded derivative and warrants of $4.4 million in the same period one year ago. Excluding the settlement accrual and the gain on embedded derivative and warrants, net loss for the six months ended June 30, 2010 improved by $1.5 million compared with the same period one year ago, driven primarily by an increase in revenues combined with an improvement in gross profit. More specifics of these areas are discussed below.
 
22

Table of Contents
Revenue and Gross Profit
The following table presents a comparison of revenue, cost of sales and gross profit for the six months ended June 30, 2010 and 2009 (in thousands, except percentages):

 	  	Six Months Ended
June 30, 2010	 	 	Six Months Ended
June 30, 2009	 	 	 	  	 	 	
 	  	Amount	  	% of
Net
Revenue	 	 	Amount	  	% of
Net
Revenue	 	 	Increase	  	%
Change	 	
Revenue	  	$	56,202	  	100	% 	 	$	47,213	  	100	% 	 	$	8,989	  	19	% 	
Cost of sales	  	 	34,154	  	61	% 	 	 	31,245	  	66	% 	 	 	2,909	  	9	% 	
	  	 	 	  	 	 	 	 	 	  	 	 	 	 	 	  	 	 	
Gross profit	  	$	22,048	  	39	% 	 	$	15,968	  	34	% 	 	$	6,080	  	38	% 	
	  	 	 	  	 	 	 	 	 	  	 	 	 	 	 	  	 	 	
Revenue. During the six months ended June 30, 2010, revenue increased 19% to $56.2 million, compared with $47.2 million in the same period one year ago. Ultracapacitor revenue increased by 61%, to $29.7 million during the six months ended June 30, 2010, compared with $18.5 million in the same period one year ago. Sales of high voltage capacitor and microelectronics products totaled $26.5 million during the six months ended June 30, 2010, down 8% from the $28.7 million recorded in the same period one year ago. The increase in revenue from our ultracapacitor product line was influenced primarily by continuing strong demand for energy storage and power delivery systems for wind turbines, hybrid transit buses and backup power.
A substantial amount of our revenue is generated through our Swiss subsidiary. As such, reported revenue can be materially impacted by the changes in exchange rates between the Swiss Franc and the U.S. dollar, our reporting currency. Due to the weakening of the U.S. Dollar against the Swiss Frank during the six months ended June 30, 2010 compared with the same period one year ago, revenue was positively impacted by $1.2 million.
Gross Profit. During the six months ended June 30, 2010, gross profit increased $6.1 million or 38% compared with the same period one year ago. As a percentage of revenue, gross profit increased to 39% compared with 34% in the same period one year ago. Higher gross profit resulted primarily from $3.1 million due to an increase in revenue volume and $3.0 million in net reductions of product costs. Product cost reductions were driven primarily by advancements in our manufacturing process and product design. The product design advancements  allowed us to reduce product cost while improving the performance of our large cell ultracapacitor product line.
Selling, General & Administrative (SG&A) Expense
The following table presents a comparison of selling, general and administrative expense for the six months ended June 30, 2010 and 2009 (in thousands, except percentages):

 	  	Six Months Ended
June 30, 2010	 	 	Six Months Ended
June 30, 2009	 	 	 	  	 	 	
 	  	Amount	  	% of
Net
Revenue	 	 	Amount	  	% of
Net
Revenue	 	 	Increase	  	%
Change	 	
Selling, general and administrative	  	$	18,339	  	33	% 	 	$	10,674	  	23	% 	 	$	7,665	  	72	% 	
SG&A expenses were 33% of revenue for the six months ended June 30, 2010, up from 23% in the same period one year ago, and total expenses increased $7.7 million, or 72%, from the same period one year ago. The increase in absolute dollars and as a percentage of revenue was driven primarily by a $3.4 million additional accrual for the potential settlement of alleged FCPA violations, approximately $1.3 million of net foreign exchange transaction losses during the six months ended June 30, 2010 compared with approximately $900,000 of net foreign exchange transaction gains in the same period one year ago and approximately $1.2 million in higher labor costs due to increases in our sales and marketing operations. The foreign exchange transaction losses were driven by the weakening of the Euro against the U.S. Dollar and Swiss Franc.
 
23

Table of Contents
Research & Development (R&D) Expense
The following table presents a comparison of research and development expense for the six months ended June 30, 2010 and 2009 (in thousands, except percentages):

 	  	Six Months Ended
June 30, 2010	 	 	Six Months Ended
June 30, 2009	 	 	 	  	 	 	
 	  	Amount	  	% of
Net
Revenue	 	 	Amount	  	% of
Net
Revenue	 	 	Increase	  	%
Change	 	
Research and development	  	$	8,536	  	15	% 	 	$	7,792	  	17	% 	 	$	744	  	10	% 	
R&D expenses were 15% of revenue for the six months ended June 30, 2010, compared with 17% from the same period one year ago, while total expenses increased by $744,000, or 10%. The increase in absolute dollars was driven primarily by increases of $265,000 of materials related to new product development, $232,000 of labor expense and $141,000 of consulting expense.
Provision for Income Taxes
We recorded an income tax provision of $719,000 for the six months ended June 30, 2010 compared with $442,000 for the same period in 2009. This provision is related to taxes on income generated by our Swiss subsidiary. Unremitted earnings of foreign subsidiaries have been included in the consolidated financial statements without giving effect to the United States taxes that may be payable as it is not anticipated such earnings will be remitted to the United States.
Commitments and Contingencies
As a result of our international operations, we are subject to the U.S. Foreign Corrupt Practices Act (“FCPA”), which prohibits companies from making improper payments to foreign officials for the purpose of obtaining or keeping business. As a result of an internal review, we are currently conducting an inquiry into the nature of certain payments made to our former independent sales agent in China with respect to sales of our high voltage capacitor products produced by our Swiss subsidiary. These payments equaled the difference between our quoted price for certain products and the amount that the independent sales agent was able to sell such products to certain customers in China. These payments had previously been recorded as commissions; however, a portion of those payments may actually have been rebated directly or indirectly to customers. We recorded commissions to the agent of $585,000, $1.8 million and $653,000 for the years ended December 31, 2009, 2008 and 2007, respectively. These commissions were based on sales of $3.1 million, $8.2 million and $3.4 million for the years ended December 31, 2009, 2008 and 2007, respectively. These amounts were previously recorded as revenue and commission expense; however, they have been reclassified as a reduction to revenue for all periods presented. The Company terminated its relationship with this independent sales agent as of May 20, 2009.
We are in the process of evaluating how these payments should be treated for FCPA purposes. Our internal review is focused on a thorough examination of all of our international operations and business practices, as well as a review of our compliance programs. We have taken certain remedial actions, including terminating our relationship with the independent sales agent in China as well as terminating our relationship with Metar SA, a former related party. The termination of these relationships and the ongoing investigation could harm our business.
We have not yet completed our internal review. As we progress, we are voluntarily sharing information related to our internal review with the Securities and Exchange Commission (“SEC”) and Department of Justice (“DOJ”) and have provided certain documents as requested by the SEC and DOJ in connection with their review of this matter. In the event that our internal review or any governmental investigation identifies violations of law, the DOJ, the SEC or other governmental authorities could seek civil and/or criminal sanctions, including monetary fines and penalties, against the Company and/or its employees, as well as additional changes to its business practices and compliance programs, which could have a material adverse effect on our business, results of operations and financial condition.
As previously disclosed, we have engaged in settlement discussions with the SEC and DOJ with regard to the ongoing FCPA investigations. We have negotiated an agreement in principle with the SEC to resolve the ongoing FCPA investigations for a payment of approximately $6.35 million in two installments, with half paid on signing and the remaining half upon the one year anniversary of the signing, as well as certain other settlement terms. The settlement with the SEC remains subject to final approval of the Commission. Settlement discussions with the DOJ are ongoing, and we have made an offer to the DOJ to settle the ongoing investigation for $6.35 million. We are awaiting a response from the DOJ to our most recent offer. As with all potential settlements with the DOJ, there are numerous other aspects of the settlement, in addition to the monetary penalties, that also need to be resolved. In the fourth quarter of 2009, we accrued $9.3 million for a potential settlement, and have accrued an additional $3.4 million in the second quarter of 2010 to reflect the full amount of our pending settlement offers to the SEC and DOJ. However, there can be no assurance that the settlement with the SEC will be approved or that the Company will be able to settle with the DOJ for $6.35 million. Previous discussions with the SEC and DOJ have resulted in an estimate of potential settlement of up to $20.0 million – representing
 
24

Table of Contents
the combined first offer of settlement put forth by the SEC and DOJ. The total accrual as of June 30, 2010 of $12.7 million represents our assessment of the best estimate of settlement  within the anticipated settlement range.
Liquidity and Capital Resources
Changes in Cash Flow
The following table summarizes our cash flows from operating, investing and financing activities for the six months ended June 30, 2010 and 2009 (in thousands):

 	  	Six Months Ended June 30,	 	
 	  	2010	 	 	2009	 	
Total cash provided by (used in):	  				 				
Operating activities	  	$	2,888	  	 	$	(574	) 	
Investing activities	  	 	(3,308	) 	 	 	(2,159	) 	
Financing activities	  	 	172	  	 	 	21,724	  	
Effect of exchange rate changes on cash and cash equivalents	  	 	(1,133	) 	 	 	(51	) 	
	  	 	 	 	 	 	 	 	
Increase (decrease) in cash and cash equivalents	  	$	(1,381	) 	 	$	18,940	  	
	  	 	 	 	 	 	 	 	
Net cash provided by operating activities was $2.9 million for the six months ended June 30, 2010, which resulted primarily from net working capital inflows of $4.4 million, offset by a net loss of $1.3 million and net non-cash gains of $123,000. The improvement in cash provided by operating activities was driven primarily by an improvement in operating results and an increase in accounts payable, offset in part by an increase in accounts receivable. The increase in accounts payable was driven primarily by an increase in payment terms and the timing of payments. The increase in accounts receivable was driven primarily by the timing of customer billings at the end of the second quarter of 2010. The net cash used in operating activities was $574,000 for the six months ended June 30, 2009, which primarily resulted from a net loss of $8.3 million, offset by net non-cash charges of $9.8 million, and net working capital outflows of $2.1 million.
Net cash used in investing activities was $3.3 million and $2.2 million for the six months ended June 30, 2010 and 2009, respectively, which resulted from capital expenditures. The majority of the capital expenditures in 2010 and 2009 have been focused on increasing our production capacity to meet anticipated increases in demand.
Net cash provided by financing activities for the six months ended June 30, 2010 was $172,000, which resulted from proceeds from short-term borrowings of $5.8 million and $510,000 from the issuance of common stock under our stock-based compensation plans, offset by payments on short-term borrowings of $6.0 million and $122,000 from the retirement of shares. The net cash provided by financing activities for the six months ended June 30, 2009 was $21.7 million, which primarily resulted from the issuance of common stock of $25.0 million and proceeds from long-term and short-term borrowing of $1.7 million, offset by principal payments on long-term and short-term debt of $5.0 million.
Liquidity
As of June 30, 2010, we had approximately $28.2 million in cash and cash equivalents with an additional $8.0 million in restricted cash for a total of $36.2 million. The cash restriction will be released when the convertible debenture is fully repaid or converted.
As discussed above, we have accrued $12.7 million for the potential settlement of alleged FCPA violations. Principal payments on our convertible debenture of $8.3 million are due throughout 2011, with the final payment due in December 2011. Additionally, we have $8.0 million of restricted cash that will be released when the debenture is fully repaid or converted. We believe that cash from operating activities, combined with available cash balances, will be sufficient to fund our working capital requirements, settlement of potential FCPA violations, debenture payments, obligations as they become due, planned capital equipment additions and product development expenditures for the next several years.
Debenture, Short-term and Long Term Borrowings
Convertible Debenture
On December 20, 2005, we issued a senior subordinated convertible debenture in aggregate principal amount of $25 million (the “Debenture”) along with warrants to purchase shares of Maxwell common stock. However, the holder, at its election, could defer each quarterly payment one time, for a 24 month period. As the holder has elected to defer some quarterly installments, the outstanding principal of the Debenture at June 30, 2010 of $8.3 million is payable in equal installments in June, September and December 2011.
Interest is due quarterly with the interest rate tied to the Federal Funds Rate plus 1.125% per annum. All or a portion of the accrued and unpaid interest may be paid in shares of Maxwell’s common stock at the Company’s option. During the six months ended June 30, 2010, we made interest payments in cash of $62,000.
 
25

Table of Contents
The change in fair value on revaluation of the Debenture conversion rights and warrant liabilities represents the difference between the fair value of the warrants and the Debenture conversion rights between the two measurement dates using a Black-Scholes calculation. The effect of the fair market value adjustment is recorded as “gain (loss) on embedded derivatives and warrants.”
The net fair value of the holder’s and Maxwell’s conversion rights at June 30, 2010 was a net liability of $775,000, and is included in “convertible debenture and long-term debt” on the balance sheet.
The warrants issued in connection with the issuance of the Debenture had a fair value at June 30, 2010 of $239,000, which is included in “stock warrants” on the balance sheet. The warrants are exercisable at any time through December 20, 2010. No warrants had been exercised through June 30, 2010.
As long as the Debenture is outstanding, the Company is required to maintain a restricted cash balance of $8.0 million.
Short-term borrowings
Maxwell’s European subsidiary, Maxwell SA, has a 3.0 million Swiss Franc denominated (approximately $2.8 million as of June 30, 2010) credit agreement with a Swiss bank, which renews quarterly and bears interest at 2.0%. Borrowings under the short-term loan agreement are unsecured and as of June 30, 2010 and December 31, 2009, the full amount of the credit line was drawn.
Maxwell SA, also has a 2.0 million Swiss Franc denominated (approximately $1.9 million as of June 30, 2010) credit agreement with a Swiss bank, which renews annually and bears interest at 3.9%. Borrowings under the credit agreement are unsecured and as of June 30, 2010 and December 31, 2009, the full amount available under the credit line was drawn.
Long-term borrowings
Maxwell SA entered into a lending agreement for the acquisition of manufacturing equipment in an amount up to 1.5 million Swiss Francs. After the acquisition of the equipment was completed the agreement converted to 48 monthly payments of 34,302 Swiss Francs with an interest rate of 2.22%. As of June 30, 2010 and December 31, 2009, the balance of the obligation was $354,000 and $543,000, respectively, with final payment due in 2011.
Critical Accounting Policies and Estimates
We describe our significant accounting policies in Note 1, Description of Business and Summary of Significant Accounting Policies , of the notes to consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009. We discuss our critical accounting estimates in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations , in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009. There has been no significant change in our significant accounting policies or critical accounting estimates since the end of fiscal 2009.
Pending Accounting Pronouncements
In January 2010, the FASB issued ASU 2010-06, Fair Value Measurements and Disclosures , to improve the disclosures about fair value measurements. This update requires us to disclose separately the amounts of significant transfers in and out of Level 1 and Level 2 fair value measurements and describe the reasons for the transfers. In the reconciliation for fair value measurements using significant unobservable inputs (Level 3), we will be required to present separately information about purchases, sales, issuances and settlements (that is, on a gross basis rather than as one net number). This update provides clarification as to the level of disaggregation in determining the appropriate classes of assets and liabilities. This update clarifies disclosures about inputs and valuation techniques for Level 2 and Level 3 fair value measurements. The new disclosures and clarifications of existing disclosures are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuances and settlements in the roll forward of activity in Level 3 fair value measurements. Those disclosures are effective for fiscal years beginning after December 15, 2010, and for interim periods within those fiscal years. As this update is only disclosure-related, it does not have an impact on our financial position or results of operations.
In October 2009, the FASB reached a consensus on ASU 2009-13, Multiple-Deliverable Revenue Arrangements , and ASU 2009-14, Certain Revenue Arrangements That Include Software Elements . ASU 2009-13 modifies the requirements that must be met for an entity to recognize revenue from the sale of a delivered item that is part of a multiple-element arrangement when other items have not yet been delivered. ASU 2009-13 eliminates the requirement that all undelivered elements must have either: i) vendor-specific objective evidence (“VSOE”) or ii) third-party evidence (“TPE”) before an entity can recognize the portion of an overall arrangement consideration that is attributable to items that already have been delivered. In the absence of VSOE or TPE of the standalone selling price for one or more delivered or undelivered elements in a multiple-element arrangement, entities will be required to estimate the selling prices of those elements. Overall arrangement consideration will be allocated to each element (both delivered and undelivered items) based on their relative selling prices, regardless of whether those selling prices are evidenced by VSOE or TPE or are based on the entity’s estimated selling price. The residual method of allocating arrangement consideration has been eliminated. ASU 2009-14 modifies the software revenue recognition guidance to exclude from its scope tangible products that contain both
 
26

Table of Contents
software and non-software components that function together to deliver a product’s essential functionality. These new updates are effective for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. Early adoption is permitted. This new pronouncement allows us to recognize revenue on multiple-deliverable arrangements earlier than in previous years. Although we are unable to estimate what those amounts will be in the future, the amounts recognized for multiple-deliverable revenue arrangements were approximately zero dollars and $896,000 for the years ended December 31, 2009 and 2008, respectively. As of June 30, 2010 and December 31, 2009, there was approximately $1.6 million and $1.9 million, respectively, of deferred revenue related to multiple-deliverable revenue arrangements.
Off Balance Sheet Arrangements
None.
 
 Item 3.	Quantitative and Qualitative Disclosures about Market Risk	
We face exposure to financial market risks, including adverse movements in foreign currency exchange rates and changes in interest rates. These exposures may change over time and could have a material adverse impact on our financial results. We have not entered into or invested in any instruments that are subject to market risk, except as follows.
Foreign Currency Risk
Our primary foreign currency exposure is related to our subsidiary in Switzerland. Maxwell SA has Euro and local currency (Swiss Franc) revenue and operating expenses as well as local currency loans. Changes in these currency exchange rates impact the reported amount (U.S. dollar) of revenue, expenses and debt. The Company has a long term contract with a customer in a currency other than U.S. dollar. A change of 100 basis points (or 1%) in the customer’s local currency would impact the value of the contract by approximately $25,000.
As part of our risk management strategy, we use forward contracts to hedge certain foreign currency exposures. Our objective is to offset gains and losses resulting from these exposures with gains and losses on the forward contracts, thereby reducing volatility of earnings. We use the forward contracts to hedge certain monetary assets and liabilities, primarily receivables and payables, denominated in a foreign currency. The change in fair value of these instruments represents a natural hedge as their gains and losses offset the changes in the underlying fair value of the monetary assets and liabilities due to movements in currency exchange rates.
Interest Rate Risk
At June 30, 2010, we had approximately $14.1 million in debt, of which $6.3 million is classified as long-term debt. Changes in interest rates may affect the consolidated balance sheet and statement of operations. The impact on earnings or cash flow during the next fiscal year from a change of 100 basis points (or 1%) in the interest rate would have a $141,000 effect on interest expense.
Fair Value Risk
We record a quarterly adjustment related to our convertible debenture to adjust the embedded conversion options and stock warrants to fair value. The change in the fair value of these instruments is impacted primarily by the price of our stock at the end of each reporting period. This adjustment creates a non-cash effect on our statement of operations which may have a significant impact.
 
 Item 4.	Controls and Procedures	
Our management evaluated, under the supervision and with the participation of our principal executive officer and our principal financial officer, the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the last fiscal quarter pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (the “Exchange Act”). Based upon their evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of June 30, 2010 to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms, and to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosures.
There was no change in our internal control over financial reporting that occurred during the period ended June 30, 2010 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
27

Table of Contents
 PART II – OTHER INFORMATION
 
 Item 1.	Legal Proceedings	
The information set forth under Note 8 of Notes to Unaudited Condensed Consolidated Financial Statements, included in Part I, Item 1 of this report, is incorporated herein by reference.
 
 Item 1A.	Risk Factors	
There have been no material changes from the risk factors disclosed in Part I, Item 1A, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009.
Item 2, 3, 4 and 5 are not applicable and have been omitted
 
 Item 6.	Exhibits	

10.1	  	Consulting Agreement effective as of June 30, 2010 between the Company and Edward Caudill. *	
		
31.1	  	Certification of Principal Executive Officer pursuant to Rule 13a-14(a) (Section 302 Certification) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *	
		
31.2	  	Certification of Principal Financial Officer pursuant to Rule 13a-14(a) (Section 302 Certification) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *	
		
32   	  	Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350 (Section 906 Certification), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *	

*	Filed herewith.	
 
28

Table of Contents
 SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: August 6, 2010	 		 	MAXWELL TECHNOLOGIES, INC.	
				
	 		 	By:	 	/s/ David J. Schramm	
	 		 		 	David J. Schramm	
	 		 		 	President and Chief Executive Officer	
				
Date: August 6, 2010	 		 	By:	 	/s/ Kevin S. Royal	
	 		 		 	Kevin S. Royal	
	 		 		 	Senior Vice President, Chief Financial Officer,	
	 		 		 	Treasurer and Secretary	
 
29

Exhibit 10.1

CONSULTING AGREEMENT
This Consulting Agreement (“Agreement”), is entered into as of the 30 th day of June, 2010 by and between Maxwell Technologies, Inc., a Delaware corporation having a principal place of business at 5271 Viewridge Ct., Ste. 100, San Diego, CA 92123 (hereinafter referred to as “M AXWELL ”), and Edward Caudill (hereinafter referred to as “C ONSULTANT ”).
WITNESSETH
WHEREAS, M AXWELL is currently engaged in the business of designing, manufacturing, marketing, and selling energy storage technology and related applications throughout the world; and
WHEREAS, C ONSULTANT was previously a member of M AXWELL ’ S Board of Directors until June 30, 2010 and, in connection with C ONSULTANT ’s resignation from M AXWELL ’ S Board of Directors effective as of June 30, 2010, M AXWELL and C ONSULTANT have agreed on the terms and conditions pursuant to which C ONSULTANT will be retained to provide consulting services to M AXWELL .
NOW, THEREFORE, the parties agree as follows:
 
1.	A PPOINTMENT OF C ONSULTANT . By this Agreement, M AXWELL appoints C ONSULTANT , and C ONSULTANT accepts such appointment, to provide advice and consulting services to M AXWELL in accordance with the terms and conditions of this Agreement. It is expressly understood and agreed that C ONSULTANT is appointed by M AXWELL and shall report to M AXWELL ’s Chairman of the Board (the “Chairman”).	
 
 	1.1.	Scope of Consulting Services . C ONSULTANT is retained to perform certain market analysis and related services (hereinafter the “Services”) on topics reasonably and mutually agreed upon by C ONSULTANT and the Chairman in writing. The deliverables for each consulting project shall include a written report to M AXWELL ’ S Board of Directors regarding the agreed upon subject matter. Unless otherwise agreed to in writing between C ONSULTANT and Chairman, it is the understanding of the parties that a written report on the agreed upon subject matter will be provided on a quarterly basis, no later than the last day of each calendar quarter. Representative consulting projects could include market analyses relating to electrical grids, trucks and other diesel-powered transportation vehicles (excluding automobiles).	
 
 	1.2.	Standard of Care . C ONSULTANT certifies that the consulting specified herein will be performed with the customary thoroughness and competence of C ONSULTANT ’s profession, in accordance with the standard for professional services of the type rendered.	
 
2.	N ATURE OF R ELATIONSHIP . The relationship of C ONSULTANT to M AXWELL is that of an independent contractor and nothing herein shall be construed as creating any other relationship. As such, C ONSULTANT shall comply with all laws and assume all risk incident to the status of independent contractor. This includes, but is not limited to, responsibility for all applicable federal and state income taxes, associated payroll and business taxes, licenses and fees, and such insurance as is necessary for the C ONSULTANT ’s protection in connection with work performed under this Agreement. It is understood that C ONSULTANT shall not be, represent, act, purport to act, or be deemed to be an agent, representative or employee, of M AXWELL . C ONSULTANT shall control the time, manner, and place of performance of the Services and shall provide all equipment and materials necessary to complete the Services.	
 
3.	C OMPENSATION . C ONSULTANT shall be compensated for the Services rendered as set forth in this Agreement.	

			
	  	Maxwell Confidential	
 
 	3.1.	Equity Component .	
 
 	3.1.1.	On February 10, 2010, C ONSULTANT was granted an award of 4,000 shares of common stock of Maxwell under the Maxwell Technologies, Inc. 2005 Omnibus Equity Incentive Plan in connection with C ONSULTANT ’s service on M AXWELL ’ S Board of Directors (the “Restricted Stock Award”). Pursuant to its terms, the Restricted Stock Award vests on February 10, 2011 (i.e., the one-year anniversary of the grant date), provided that C ONSULTANT continues to provide service as an employee or director. M AXWELL and C ONSULTANT hereby agree, subject to the approval of M AXWELL ’ S Board of Directors, that the terms of the Restricted Stock Award are amended to allow C ONSULTANT to fully vest in the Restricted Stock Award on February 10, 2011, so long as C ONSULTANT continues as a service provider to M AXWELL through such date as a consultant pursuant to the terms of this Agreement. Except as amended hereby, the Restricted Stock Award shall continue in full force and effect as originally constituted and is ratified and affirmed by the parties hereto.	
 
 	3.1.2.	C ONSULTANT ’s restricted stock units issued in connection with C ONSULTANT ’s service on M AXWELL ’ S Board of Directors and earned through June 30, 2010 shall vest and be settled 60 days following the effective date of C ONSULTANT ’s resignation from M AXWELL ’ S Board of Directors on June 30, 2010, in accordance with their terms.	
 
 	3.1.3.	C ONSULTANT further agrees that he has no additional rights in any equity awards provided to him as a director of M AXWELL and that any such rights terminated in accordance with their terms upon C ONSULTANT ’ S resignation from M AXWELL ’ S Board of Directors.	
 
 	3.2.	Consulting Fees . As compensation for the performance of the Services, C ONSULTANT shall receive $20,000 per calendar quarter during the term of this Agreement, payable in arrears within thirty (30) days following the end of the calendar quarter. For the avoidance of doubt, (i) the maximum aggregate amount payable under this Agreement shall not exceed $120,000 for the six calendar quarters during the term of this Agreement, subject to termination for Cause (as defined in Section 4 below) and (ii) the first quarterly payment of $20,000 shall cover June 30, 2010 through September 30, 2010.	
 
 	3.3.	Reimbursement of Expenses . C ONSULTANT shall not be reimbursed for any business and travel expenses incurred by C ONSULTANT in performing the Services, unless otherwise agreed in advance and in writing by the Chairman.	
 
 	3.4.	Withholding and Benefits . All fees payable to C ONSULTANT under this Agreement shall be made in full, and without any withholding, deduction, or offset of any state or federal withholding taxes, FICA, SDI, or income taxes, nor shall M AXWELL be obligated to pay any of C ONSULTANT ’s employees’ taxes. C ONSULTANT hereby covenants and agrees that it shall be solely responsible for all taxes, withholding, FICA, SDI, and other similar items (both employee and employer portions) with respect to all fees paid by M AXWELL under this Agreement, and agrees to indemnify and hold M AXWELL harmless with respect to such taxes and withholding. C ONSULTANT shall not be eligible for, participate in, or be entitled to any insurance, benefit, retirement, or other plan or program provided by M AXWELL to its employees.	
 
4.	T ERM OF THE A GREEMENT . Except as provided below, this Agreement, and the Services to be performed under it, shall commence on the date of this Agreement, and shall continue thereafter through December 31, 2011, at which time this Agreement shall automatically terminate.	
 
 	4.1.	Termination for Cause . M AXWELL shall have the right to terminate this Agreement for Cause. For purposes of this Agreement, “Cause” shall mean: (i) indictment or conviction of any felony or of any crime involving dishonesty; (ii) participation in any fraud against M AXWELL ; or (iii) failure to deliver the Services as required under this Agreement. With respect to any alleged Cause in subcategory (iii), the Consulting Agreement shall not be terminated until 30 days after	

Consulting Agreement – Edward Caudill	  	Page 2 of 4	

			
	  	Maxwell Confidential	
 
 	C ONSULTANT receives specified written notice of the alleged Cause, and only if C ONSULTANT has not cured the alleged Cause by that date.	
 
 	4.2.	Final Payment . Upon termination or cancellation of this Agreement which results in a pay period less than a calendar quarter, C ONSULTANT shall be paid a pro rated amount for such calendar quarter from the beginning of such calendar quarter to the time specified in the termination or cancellation notice.	
 
 	4.3.	Survivability . The terms and conditions in this Agreement that by their sense and context are intended to survive the performance hereof by either or both parties shall so survive the termination, cancellation, or completion of performance of this Agreement.	
 
5.	C ONFIDENTIALITY . C ONSULTANT agrees to keep in confidence and protect all information disclosed to C ONSULTANT during the term of this Agreement using a standard of at least reasonable care for a period of five (5)  years from its receipt, and in no event will use a standard of care that is less than it employs with respect to its own confidential information. In addition, C ONSULTANT agrees that it will not disclose to others, duplicate, or use such information for any purpose other than that for which it is intended without the prior written consent of M AXWELL . C ONSULTANT further agrees that during and after the termination of this Agreement, C ONSULTANT will not utilize any of M AXWELL ’s confidential or proprietary information to interfere, disrupt, damage, impair, or interfere with the employees or business of M AXWELL .	
 
 	5.1.	Definitions . For purposes of this Agreement, confidential or proprietary information is that which M AXWELL wishes to maintain control by preventing its unauthorized use, reproduction or disclosure, except that it is expressly understood by both parties that proprietary or confidential information does not include:	
 
 	•	 	Information which at the time of disclosure is in the public domain; or	
 
 	•	 	Information which, after disclosure, is published or otherwise becomes part of the public domain through no fault of C ONSULTANT ; or	
 
 	•	 	Information which C ONSULTANT can show was received by it after the time of disclosure hereunder from a third party who did not require C ONSULTANT to hold it in confidence and who did not acquire it, directly or indirectly, from M AXWELL ; or	
 
 	•	 	Information which was known to C ONSULTANT prior to the time of the disclosure; or	
 
 	•	 	Information which is disclosed with the prior written permission of M AXWELL ; or	
 
 	•	 	Information which is independently developed by C ONSULTANT , as evidenced by its business records.	
 
6.	W ORK P RODUCT . The results of work performed under this Agreement by C ONSULTANT are the property of M AXWELL .	
 
7.	A DDITIONAL P ROVISIONS 	
 
 	7.1.	Public Release of Information . No information relating to this Agreement or work performed under this Agreement shall be released to third parties without advance written approval of M AXWELL . In no event shall the interest of M AXWELL in any work performed by C ONSULTANT under this Agreement be included in any advertising without advanced written approval of M AXWELL . Requests for such authorization shall be forwarded to M AXWELL at least eight (8) weeks in advance of the date of presentation or publication.	
 
 	7.2.	Indemnification . C ONSULTANT shall indemnify, defend and hold harmless M AXWELL from and against any and all claims and actions and all expenses incidental to such claims or actions, based upon or arising out of damage to property or injuries to persons or other tortious acts caused or contributed to by C ONSULTANT or anyone acting under C ONSULTANT ’s direction or control or on C ONSULTANT ’s behalf in the course of performing services under this Agreement. Should	

Consulting Agreement – Edward Caudill	  	Page 3 of 4	

			
	  	Maxwell Confidential	
 
 	performance of work under this Agreement require C ONSULTANT to enter premises of M AXWELL , C ONSULTANT shall indemnify, defend and hold harmless M AXWELL from and against all claims for bodily injuries, including death, or damage to property caused by the condition of any premises, equipment, or other property being used or operated by C ONSULTANT .	
 
 	7.3.	Entire Agreement . This Agreement constitutes the entire agreement between M AXWELL and C ONSULTANT . It supersedes all prior or contemporaneous communications, representations or agreements whether oral or written with respect to the subject matter thereof and has been induced by no representations, statements, or agreements other than those herein expressed. No agreement hereafter made between the parties shall be binding on either party unless reduced to writing and signed by an authorized representative of the party sought to be bound thereby.	
 
 	7.4.	Severability . The provisions of this Agreement are severable, and if any part of it is found to be unenforceable, the other paragraphs shall remain fully valid and enforceable.	
 
 	7.5.	Remedies . In the event that C ONSULTANT breaches or threatens to breach any covenants expressed in this Agreement both parties agree that irreparable harm may occur and that M AXWELL shall be entitled to injunctive and equitable relief to restrain such breach, in addition to all other remedies available to M AXWELL at law or in equity. C ONSULTANT agrees it will indemnify and hold harmless M AXWELL from losses, damages, causes of action, and attorney’s fees incurred by M AXWELL arising from the breach of this Agreement by C ONSULTANT .	
 
 	7.6.	Governing Law . The validity, performance and all matters relating to the interpretation and effect of this Agreement shall be governed by the laws of the State of California.	
IN WITNESS WHEREOF, THE PARTIES HERETO HAVE EXECUTED THIS AGREEMENT AS OF THE DATE AND YEAR FIRST WRITTEN ABOVE.

Maxwell Technologies, Inc.	 		 	Consultant	
			
/s/ Robert Guyett	 		 	/s/ Edward Caudill	
Robert Guyett, Chairman of the Board	 		 	Edward Caudill	

Consulting Agreement – Edward Caudill	  	Page 4 of 4	

Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
I, David J. Schramm, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Maxwell Technologies, Inc. for the quarter ended June 30, 2010.
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 6, 2010	 		 		 	MAXWELL TECHNOLOGIES, INC.	
					
	 		 		 	By:	 	/s/ David J. Schramm	
	 		 		 		 	David J. Schramm	
	 		 		 		 	President and Chief Executive Officer	
	 		 		 		 	(Principal Executive Officer)	

Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
I, Kevin S. Royal, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Maxwell Technologies, Inc. for the quarter ended June 30, 2010.
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 6, 2010	 		 	By:	 	/s/ Kevin S. Royal	
	 		 		 	Kevin S. Royal	
	 		 		 	Senior Vice President, Chief Financial Officer,	
	 		 		 	Treasurer and Secretary	
	 		 		 	(Principal Financial Officer)	

Exhibit 32
Certification of Periodic Financial Report by the Principal Executive Officer and
Principal Financial Officer
Solely for the purpose of complying with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Chief Executive Officer and Chief Financial Officer of Maxwell Technologies, Inc. (the “Company”), hereby certify that, based on our knowledge, the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 6, 2010	 	   	 	MAXWELL TECHNOLOGIES, INC.	
				
	 		 	By:	 	/s/ David J. Schramm	
	 		 		 	David J. Schramm	
	 		 		 	President and Chief Executive Officer	
	 		 		 	(Principal Executive Officer)	
				
Date: August 6, 2010	 		 	By:	 	/s/ Kevin S. Royal	
	 		 		 	Kevin S. Royal	
	 		 		 	Senior Vice President, Chief Financial Officer,	
	 		 		 	Treasurer and Secretary	
	 		 		 	(Principal Financial Officer)